UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 | |
For the quarterly period ended March 28, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 | |
For the transition period from __________ to __________
Commission File Number: 000-02382
(Exact name of Registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||
(Address of principal executive offices) | (Zip Code) | ||
Registrant's telephone number, including area code: (952 ) 937-4000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
☒ | Accelerated filer ☐ | Emerging growth company | |||
Non-accelerated filer ☐ | Smaller reporting company | ||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No
As of April 30, 2020, there were 19,235,943 shares of common stock outstanding.
MTS Systems Corporation
Quarterly Report on Form 10-Q
For the Three Months Ended March 28, 2020
Table of Contents
1
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
MTS SYSTEMS CORPORATION
Consolidated Balance Sheets
(in thousands, except per share data)
March 28, 2020 | September 28, 2019 | |||||||
(Unaudited) | (Note) | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | $ | ||||||
Accounts receivable, net of allowance for doubtful accounts of $4,648 and $5,963, respectively | ||||||||
Unbilled accounts receivable, net | ||||||||
Inventories, net | ||||||||
Prepaid expenses and other current assets | ||||||||
Total current assets | ||||||||
Property and equipment, net | ||||||||
Goodwill | ||||||||
Intangible assets, net | ||||||||
Other long-term assets | ||||||||
Deferred income taxes | ||||||||
Total assets | $ | $ | ||||||
Liabilities and Shareholders' Equity | ||||||||
Current liabilities | ||||||||
Short-term borrowings | $ | $ | ||||||
Current maturities of long-term debt, net | ||||||||
Accounts payable | ||||||||
Accrued payroll and related costs | ||||||||
Advance payments from customers | ||||||||
Accrued warranty costs | ||||||||
Accrued income taxes | ||||||||
Accrued dividends | ||||||||
Other accrued liabilities | ||||||||
Total current liabilities | ||||||||
Long-term debt, less current maturities, net | ||||||||
Deferred income taxes | ||||||||
Non-current accrued income taxes | ||||||||
Defined benefit pension plan obligation | ||||||||
Contingent consideration | ||||||||
Other long-term liabilities | ||||||||
Total liabilities | ||||||||
Shareholders' Equity | ||||||||
Common stock, $0.25 par value; 64,000 shares authorized: 19,188 and 19,124 shares issued and outstanding as of March 28, 2020 and September 28, 2019, respectively | ||||||||
Additional paid-in capital | ||||||||
Retained earnings | ||||||||
Accumulated other comprehensive income (loss) | ( | ) | ( | ) | ||||
Total shareholders' equity | ||||||||
Total liabilities and shareholders' equity | $ | $ | ||||||
Note: The Consolidated Balance Sheet as of September 28, 2019 has been derived from the audited consolidated financial statements at that date.
The accompanying Notes to Consolidated Financial Statements (Unaudited) are an integral part of these consolidated financial statements.
2
MTS SYSTEMS CORPORATION
Consolidated Statements of Income (Unaudited)
(in thousands, except per share data)
Three Months Ended | Six Months Ended | |||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||
Revenue | ||||||||||||||||
Product | $ | $ | $ | $ | ||||||||||||
Service | ||||||||||||||||
Total revenue | ||||||||||||||||
Cost of Sales | ||||||||||||||||
Product | ||||||||||||||||
Service | ||||||||||||||||
Total cost of sales | ||||||||||||||||
Gross profit | ||||||||||||||||
Operating expenses | ||||||||||||||||
Selling and marketing | ||||||||||||||||
General and administrative | ||||||||||||||||
Research and development | ||||||||||||||||
Total operating expenses | ||||||||||||||||
Income from operations | ||||||||||||||||
Interest income (expense), net | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Other income (expense), net | ( | ) | ( | ) | ||||||||||||
Income (loss) before income taxes | ( | ) | ||||||||||||||
Income tax provision | ||||||||||||||||
Net income (loss) | $ | ( | ) | $ | $ | $ | ||||||||||
Earnings (loss) per share | ||||||||||||||||
Basic | ||||||||||||||||
Earnings (loss) per share | $ | ( | ) | $ | $ | $ | ||||||||||
Weighted average common shares outstanding | ||||||||||||||||
Diluted | ||||||||||||||||
Earnings (loss) per share | $ | ( | ) | $ | $ | $ | ||||||||||
Weighted average common shares outstanding | ||||||||||||||||
Dividends declared per share | $ | $ | $ | $ | ||||||||||||
The accompanying Notes to Consolidated Financial Statements (Unaudited) are an integral part of these consolidated financial statements.
3
MTS SYSTEMS CORPORATION
Consolidated Statements of Comprehensive Income (Unaudited)
(in thousands)
Three Months Ended | Six Months Ended | |||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||
Net income (loss) | $ | ( | ) | $ | $ | $ | ||||||||||
Other comprehensive income (loss), net of tax | ||||||||||||||||
Foreign currency translation gain (loss) adjustments | ( | ) | ( | ) | ( | ) | ||||||||||
Derivative instruments | ||||||||||||||||
Unrealized net gain (loss) | ( | ) | ( | ) | ||||||||||||
Net (gain) loss reclassified to earnings | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Defined benefit pension plan | ||||||||||||||||
Unrealized net gain (loss) | ( | ) | ( | ) | ( | ) | ||||||||||
Net (gain) loss reclassified to earnings | ||||||||||||||||
Currency exchange rate gain (loss) | ( | ) | ||||||||||||||
Other comprehensive income (loss) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Comprehensive income (loss) | $ | ( | ) | $ | $ | $ | ||||||||||
The accompanying Notes to Consolidated Financial Statements (Unaudited) are an integral part of these consolidated financial statements.
4
MTS SYSTEMS CORPORATION
Consolidated Statements of Shareholders' Equity (Unaudited)
(in thousands)
Three Months Ended March 28, 2020 | |||||||||||||||||||||||
Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Total Shareholders' Equity | ||||||||||||||||||||
Shares Issued | Amount | Retained Earnings | |||||||||||||||||||||
Balance, December 28, 2019 | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||
Total comprehensive income (loss) | — | — | — | ( | ) | ( | ) | ( | ) | ||||||||||||||
Stock-based compensation | — | — | |||||||||||||||||||||
Issuance for employee stock purchase plan | — | — | |||||||||||||||||||||
Common stock purchased and retired | ( | ) | ( | ) | ( | ) | — | — | ( | ) | |||||||||||||
Dividends, $0.30 per share | — | — | — | ( | ) | — | ( | ) | |||||||||||||||
Balance, March 28, 2020 | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||
Six Months Ended March 28, 2020 | |||||||||||||||||||||||
Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Total Shareholders' Equity | ||||||||||||||||||||
Shares Issued | Amount | Retained Earnings | |||||||||||||||||||||
Balance, September 28, 2019 | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||
Total comprehensive income | — | — | — | ( | ) | ||||||||||||||||||
Exercise of stock options | — | — | — | ||||||||||||||||||||
Stock-based compensation | — | — | |||||||||||||||||||||
Issuance for employee stock purchase plan | — | — | |||||||||||||||||||||
Common stock purchased and retired | ( | ) | ( | ) | ( | ) | — | — | ( | ) | |||||||||||||
Dividends, $0.60 per share | — | — | — | ( | ) | — | ( | ) | |||||||||||||||
Balance, March 28, 2020 | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||
5
Three Months Ended March 30, 2019 | |||||||||||||||||||||||
Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Total Shareholders' Equity | ||||||||||||||||||||
Shares Issued | Amount | Retained Earnings | |||||||||||||||||||||
Balance, December 29, 2018 | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||
Total comprehensive income | — | — | — | ( | ) | ||||||||||||||||||
Exercise of stock options | — | — | |||||||||||||||||||||
Stock-based compensation | — | — | |||||||||||||||||||||
Issuance for employee stock purchase plan | — | — | |||||||||||||||||||||
Common stock purchased and retired | ( | ) | — | ( | ) | — | — | ( | ) | ||||||||||||||
Dividends, $0.30 per share | — | — | — | ( | ) | — | ( | ) | |||||||||||||||
Balance, March 30, 2019 | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||
Six Months Ended March 30, 2019 | |||||||||||||||||||||||
Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Total Shareholders' Equity | ||||||||||||||||||||
Shares Issued | Amount | Retained Earnings | |||||||||||||||||||||
Balance, September 29, 2018 | $ | $ | $ | $ | $ | ||||||||||||||||||
Total comprehensive income | — | — | — | ( | ) | ||||||||||||||||||
Cumulative effect of accounting change | — | — | — | ( | ) | — | ( | ) | |||||||||||||||
Exercise of stock options | — | — | |||||||||||||||||||||
Stock-based compensation | — | — | |||||||||||||||||||||
Issuance for employee stock purchase plan | — | — | |||||||||||||||||||||
Common stock purchased and retired | ( | ) | ( | ) | ( | ) | — | — | ( | ) | |||||||||||||
Dividends, $0.60 per share | — | — | — | ( | ) | — | ( | ) | |||||||||||||||
Balance, March 30, 2019 | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||
The accompanying Notes to Consolidated Financial Statements (Unaudited) are an integral part of these consolidated financial statements.
6
MTS SYSTEMS CORPORATION
Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
Six Months Ended | ||||||||
March 28, 2020 | March 30, 2019 | |||||||
Cash Flows from Operating Activities | ||||||||
Net income | $ | $ | ||||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities | ||||||||
Stock-based compensation | ||||||||
Fair value adjustment to acquired inventory | ||||||||
Net periodic pension benefit cost | ||||||||
Depreciation | ||||||||
Amortization | ||||||||
Accretion of contingent consideration | ||||||||
(Gain) loss on sale or disposal of property and equipment | ||||||||
Amortization of debt issuance costs | ||||||||
Deferred income taxes | ( | ) | ||||||
Bad debt provision (recovery), net | ( | ) | ||||||
Changes in operating assets and liabilities | ||||||||
Accounts receivable and unbilled accounts receivable | ( | ) | ||||||
Inventories, net | ( | ) | ( | ) | ||||
Prepaid expenses | ( | ) | ||||||
Accounts payable | ( | ) | ||||||
Accrued payroll and related costs | ( | ) | ( | ) | ||||
Advance payments from customers | ( | ) | ||||||
Accrued warranty costs | ( | ) | ||||||
Other assets and liabilities | ( | ) | ||||||
Net Cash Provided by (Used in) Operating Activities | ( | ) | ||||||
Cash Flows from Investing Activities | ||||||||
Purchases of property and equipment | ( | ) | ( | ) | ||||
Proceeds from sale of property and equipment | ||||||||
Purchases of business, net of acquired cash | ( | ) | ( | ) | ||||
Other | ( | ) | ||||||
Net Cash Provided by (Used in) Investing Activities | ( | ) | ( | ) | ||||
Cash Flows from Financing Activities | ||||||||
Proceeds from issuance of long-term debt | ||||||||
Payment of long-term debt | ( | ) | ( | ) | ||||
Payment of debt issuance costs for long-term debt | ( | ) | ||||||
Payment of debt component of tangible equity units | ( | ) | ||||||
Payment of debt issuance costs for revolving credit facility | ( | ) | ( | ) | ||||
Receipts under short-term borrowings | ||||||||
Payments under short-term borrowings | ( | ) | ( | ) | ||||
Cash dividends | ( | ) | ( | ) | ||||
Proceeds from exercise of stock options and employee stock purchase plan | ||||||||
Payments to purchase and retire common stock | ( | ) | ( | ) | ||||
Net Cash Provided by (Used in) Financing Activities | ||||||||
Effect of Exchange Rate Changes on Cash and Cash Equivalents | ( | ) | ( | ) | ||||
Cash and Cash Equivalents | ||||||||
Increase (decrease) in cash and cash equivalents during the period | ||||||||
Cash and cash equivalents balance, beginning of period | ||||||||
Cash and cash equivalents balance, end of period | $ | $ | ||||||
Supplemental Disclosures | ||||||||
Cash paid during the period for | ||||||||
Interest | $ | $ | ||||||
Income taxes | ||||||||
Non-cash investing and financing activities | ||||||||
Contingent consideration assumed in acquisition | ||||||||
Dividends declared not yet paid | ||||||||
The accompanying Notes to Consolidated Financial Statements (Unaudited) are an integral part of these consolidated financial statements.
7
MTS SYSTEMS CORPORATION
Notes to Consolidated Financial Statements (Unaudited)
(Dollars and shares in thousands, unless otherwise noted)
NOTE 1 BASIS OF PRESENTATION
The consolidated financial statements include the accounts of MTS Systems Corporation and its wholly owned subsidiaries. Significant intercompany account balances and transactions have been eliminated.
The terms "MTS," "we," "us," "the Company" or "our" in this Quarterly Report on Form 10-Q, unless the context otherwise requires, refer to MTS Systems Corporation and its wholly owned subsidiaries.
Changes to Significant Accounting Policies
The following accounting policies have been updated since our fiscal year 2019 Annual Report on Form 10-K.
Leases
Business Acquisitions
COVID-19
The global spread of COVID-19 has created significant volatility, uncertainty and economic disruption. See Note 17 for further information on our risks and uncertainties related to COVID-19.
NOTE 2 RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
In June 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, followed by related amendments, which changes the accounting for credit losses on instruments measured at amortized cost by adding an impairment model that is based on expected losses rather than incurred losses. An entity will recognize as an allowance its estimate of expected credit losses, which is believed to result in more timely recognition of such losses as the standard eliminates the probable initial recognition threshold. Adoption of the standard is required for annual periods beginning after December 15, 2019, including interim periods within that annual period, which is our fiscal year 2021. The new guidance is required to be adopted using a modified retrospective approach with a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period of adoption. We have not yet evaluated the impact the adoption of this guidance may have on our financial condition, results of operations or disclosures.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurements (Topic 820): Disclosure Framework–Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates, amends and adds disclosure requirements for
8
fair value measurements. The standard is required to be adopted for annual periods beginning after December 15, 2019, including interim periods within that annual period, which is our fiscal year 2021. Certain disclosures in the new guidance are to be applied using a retrospective approach while other disclosures are to be applied using a prospective approach. Early adoption is permitted. We do not expect the adoption of this standard to have a material impact on our financial condition, results of operations or disclosures.
In August 2018, the FASB issued ASU No. 2018-14, Compensation–Retirement Benefits–Defined Benefit Plans–General (Subtopic 715-20): Disclosure Framework–Changes to the Disclosure Requirements for Defined Benefit Plans, which eliminates, amends and adds disclosure requirements for defined benefit pension and other postretirement plans. The standard is required to be adopted for annual periods ending after December 15, 2020, which is our fiscal year 2021. The new guidance is to be applied using a retrospective approach with early adoption permitted. We do not expect the adoption of this standard to have a material impact on our financial condition, results of operations or disclosures.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which eliminates certain exceptions to Topic 740's general principles, improves consistent application and simplifies its application. The standard is required to be adopted for annual periods ending after December 15, 2020, which is our fiscal year 2021. We have not yet evaluated the impact the adoption of this guidance may have on our financial condition, results of operations or disclosures.
In April 2020, the FASB issued ASU No. 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides relief for companies preparing for discontinuation of interest rates such as LIBOR. The standard can be applied immediately through December 31, 2022, which is our fiscal year 2023. We have not yet evaluated the impact the adoption of this guidance may have on our financial condition, results of operations or disclosures.
Adopted
In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), followed by related amendments (collectively, "the new lease standard"), which requires lessees to recognize most leases on the balance sheet for the rights and obligations created by those leases. We adopted the new lease standard on September 29, 2019 under the modified retrospective transition method and the optional transition method. As a result, we did not adjust our comparative period financial information or make the new required lease disclosures for periods before the effective date. We elected the package of practical expedients to not reassess prior conclusions related to contracts containing leases, lease classification and initial direct costs. In addition, we did not elect to apply the hindsight practical expedient. See Note 5 for our new lease accounting policy and disclosures related to the new lease standard.
NOTE 3 REVENUE
Revenue Recognition
Revenue is recognized when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for transferring those goods or providing those services. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are known, the contract has commercial substance and collectability of consideration is probable.
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account under the revenue recognition standard. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Many of our contracts have a single performance obligation as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts and, therefore, not distinct. In situations when our contract includes distinct goods or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct goods or services. For contracts with multiple performance obligations, we allocate the contract's transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract.
We do not adjust the promised amount of consideration for the effects of a significant financing component if we expect, at contract inception, that the period between when we transfer a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Revenue is recorded net of taxes collected from customers, and taxes collected are recorded as current liabilities until remitted to the relevant government authority. Shipping and handling costs associated with outbound freight after control of a product has transferred are accounted for as a fulfillment cost and are included in cost of sales in the Consolidated Statements of Income.
9
The following is a description of the product offerings, end markets, typical revenue transactions and payment terms for each of our two reportable segments. See Note 14 for further information on reportable segments.
Test & Simulation
Our Test & Simulation segment (Test & Simulation) manufactures and sells equipment and related software and services which are used by customers to characterize a product's mechanical properties or performance or to create a desired human experience. Our solutions simulate forces and motions that customers expect their products to encounter in use or are necessary to properly characterize the product's performance. Primary Test & Simulation markets include transportation, infrastructure, energy, aerospace, materials science, medical, flight training and amusement parks. A typical system is a comprehensive solution which includes a platform on which a human or prototype specimen resides or a reaction frame to hold the prototype specimen; a hydraulic or electro-mechanical power source; actuators to create the force or motion; and a computer controller with specialized software to coordinate the actuator movement and to measure, record, analyze and manipulate results. Our portfolio of Test & Simulation solutions includes standard, configurable products; engineered products which combine standard product configurations with a moderate degree of customization per customer specifications; and highly customized, highly engineered solutions built to address the customer's unique business need, which can include development of first-of-a-kind technology. To complement our Test & Simulation products, we provide our customers with a spectrum of services to maximize product performance including installation, product life cycle management, professional training, calibration and metrology, technical consulting and onsite and factory repair and maintenance. In addition, we sell a variety of accessories and spare parts. The manufacturing cycle for a typical system ranges from weeks to 12 months, depending on the complexity of the system and the availability of components, and can be several years for larger, more complex systems. For certain contracts, the order to revenue cycle may extend beyond the manufacturing cycle, such as when the manufacturing start date is driven by the customer's project timeline or when the contract terms require equipment installation and commissioning and customer acceptance prior to point-in-time revenue recognition.
Test & Simulation contracts often have multiple performance obligations, most commonly due to the contract covering multiple phases of the product life cycle (i.e., equipment design and production, installation and commissioning, extended warranty and software maintenance). The primary method used to estimate standalone selling price is the expected cost plus a margin approach under which we forecast our expected costs of satisfying a performance obligation and then add an appropriate margin for that distinct good or service.
Test & Simulation revenue is recognized either over time as work progresses or point-in-time, depending on contract-specific terms and the pattern of transfer of control of the product or service to the customer. Revenue from services is recognized in the period the service is performed or ratably over the period of the related service contract. Equipment revenue is recognized over time when: (i) control is transferred to the customer over time as work progresses; or (ii) contract terms evidence customer control of the work in process or an enforceable right to payment with no alternative use. Equipment revenue is recognized over time using costs incurred to date relative to total estimated costs at completion to measure progress toward satisfying the performance obligation. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer. Equipment contract costs include materials, component parts, labor and overhead costs.
Equipment revenue is recognized point-in-time when either: (i) control is transferred to the customer at a point-in-time when obligations under the terms of the contract are satisfied; or (ii) contract terms do not evidence customer control of the work in process or an enforceable right to payment with no alternative use, and consequently revenue is deferred as work progresses. Satisfaction of performance obligations under the terms of the contract occurs either upon product shipment (as evidenced by delivery or shipment terms), completion of equipment installation and commissioning, or customer acceptance.
For our Test & Simulation contracts with customers, payment terms vary and are subject to negotiation. Typical payment terms include progress payments based on specified events or milestones. For some contracts, we are entitled to receive an advance payment.
Sensors
Our Sensors segment (Sensors) manufactures and sells high-performance sensors which provide measurements of vibration, pressure, position, force and sound in a variety of applications. Our Sensors products are used to enable automation, enhance precision and safety, and lower our customers' production costs by improving performance and reducing downtime. Primary Sensors markets include transportation, aerospace and defense, industrial, and research and development. Our Sensors products are sold as configurable, standard units; utilize piezoelectric or magnetostriction technology; and are ideal for use in harsh operating environments to provide accurate and reliable sensor information. To complement our Sensors products, we also provide spare parts and services. The cycle from contract inception to shipment of equipment is typically one to three months , with the exception of certain high-volume contracts which are fulfilled in a series of shipments over an extended period.
10
Our Sensors contracts generally have a single performance obligation which is satisfied at a point in time. The performance obligation is a stand-alone sensor product, accessory, service or software license. Sensors contracts are generally fixed-price purchase order fulfillment contracts, and the transaction price is equal to the observable consideration in the contract. Revenue is recognized when obligations under the terms of the contract with our customer are satisfied; generally, this occurs with the transfer of control upon product shipment (as evidenced by shipment or delivery terms) or with the performance of the service. Certain contracts are measured using the as invoiced practical expedient as we have a right to consideration from a customer in an amount that corresponds directly with the value to the customer of our performance completed to date.
For our Sensors contracts with customers, payment terms are generally within 90 days. The timing of satisfying our Sensors performance obligations does not vary significantly from the typical timing of payment. For certain high-volume contracts, we are entitled to receive an advance payment.
11
Disaggregation of Revenue
We disaggregate our revenue by reportable segment, sales type (product or service), the timing of recognition of revenue for transfer of goods or services to customers (point-in-time or over time), and geographic market based on the billing location of the customer. See Note 14 for further information on our reportable segments and intersegment revenue.
Three Months Ended | ||||||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | |||||||||||||||||||||||||||||||
Test & Simulation | Sensors | Intersegment | Total | Test & Simulation | Sensors | Intersegment | Total | |||||||||||||||||||||||||
Sales type | ||||||||||||||||||||||||||||||||
Product | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Service | ( | ) | ||||||||||||||||||||||||||||||
Total revenue | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Timing of recognition | ||||||||||||||||||||||||||||||||
Point-in-time | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Over time | ||||||||||||||||||||||||||||||||
Total revenue | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Geographic market | ||||||||||||||||||||||||||||||||
Americas | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Europe | ||||||||||||||||||||||||||||||||
Asia | ||||||||||||||||||||||||||||||||
Total revenue | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Six Months Ended | ||||||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | |||||||||||||||||||||||||||||||
Test & Simulation | Sensors | Intersegment | Total | Test & Simulation | Sensors | Intersegment | Total | |||||||||||||||||||||||||
Sales type | ||||||||||||||||||||||||||||||||
Product | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Service | ( | ) | ||||||||||||||||||||||||||||||
Total revenue | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Timing of recognition | ||||||||||||||||||||||||||||||||
Point-in-time | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Over time | ||||||||||||||||||||||||||||||||
Total revenue | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Geographic market | ||||||||||||||||||||||||||||||||
Americas | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
Europe | ||||||||||||||||||||||||||||||||
Asia | ||||||||||||||||||||||||||||||||
Total revenue | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
12
Contract assets and contract liabilities are as follows:
March 28, 2020 | September 28, 2019 | |||||||
Contract assets | $ | $ | ||||||
Contract liabilities | ||||||||
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled accounts receivable (contract assets) and advance payments from customers (contract liabilities). Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period. Contract liabilities represent payments received from customers at contract inception and at milestones per contract provisions. These payments are recorded in advance payments from customers and other long-term liabilities in our Consolidated Balance Sheets (current and non-current portions, respectively) and are liquidated as revenue is recognized. Conversely, when billing occurs subsequent to revenue recognition for contracts recognized over time, balances are recorded in unbilled accounts receivable, net in our Consolidated Balance Sheets. As customers are billed, unbilled accounts receivable balances are transferred to accounts receivable, net in the Consolidated Balance Sheets.
Significant changes in contract assets and contract liabilities are as follows:
Contract Assets | ||||
Balance, September 28, 2019 | $ | |||
Changes in estimated stage of completion | ||||
Transfers to accounts receivable, net | ( | ) | ||
Acquisitions1 | ||||
Other | ( | ) | ||
Balance, March 28, 2020 | $ | |||
Contract Liabilities | ||||
Balance, September 28, 2019 | $ | |||
Revenue recognized included in balance at beginning of period | ( | ) | ||
Increases due to payments received, excluding amounts recognized as revenue during period | ||||
Acquisitions1 | ||||
Other | ( | ) | ||
Balance, March 28, 2020 | $ | |||
1 See Note 16 for additional information regarding acquisitions.
Remaining Performance Obligations
As of March 28, 2020, we had approximately $228,500 of remaining performance obligations on contracts with an original expected duration of one year or more which are primarily related to Test & Simulation. As of March 28, 2020, we expect to recognize approximately 57 % of these remaining performance obligations as revenue within one year, an additional 23 % within two years and the balance thereafter. We do not disclose the value of remaining performance obligations for contracts with an original expected duration of one year or less.
Contract Estimates
For contracts recognized over time, we estimate the profit on a contract as the difference between the total estimated revenue and expected costs to complete a contract and recognize that profit over the life of the contract. Contract estimates are based on various assumptions to project the outcome of future events that may span several years. These assumptions include labor productivity and availability, the complexity of the work to be performed, the cost and availability of materials, and internal and subcontractor performance.
Pricing is established at or prior to the time of sale with our customers, and we record sales at the agreed-upon selling price. The terms of a contract or the historical business practice can give rise to variable consideration due to but not limited to volume discounts, penalties and early payment discounts. We estimate variable consideration at the most likely amount we will receive from customers. We include estimated amounts in the transaction price to the extent it is probable that a significant
13
reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. In general, variable consideration in our contracts relates to the entire contract. As a result, the variable consideration is allocated proportionately to all performance obligations. Our estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information (historical, current and forecasted) that is reasonably available to us at contract inception. There are no significant instances where variable consideration is constrained and not recorded at the initial time of sale.
As a significant change in one or more of these estimates could affect the profitability of our contracts, we review and update our contract-related estimates regularly. We recognize adjustments in estimated profit on contracts under the cumulative catch-up method. Under this method, the impact of the adjustment on profit recorded to date is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance is recognized using the adjusted estimate. If at any time the estimate of contract profitability indicates an anticipated loss on the contract, we recognize the total loss in the period it is identified. Our review of contract-related estimates has not resulted in adjustments that are significant to our results of operations.
Contract Modifications
When contracts are modified to account for changes in contract specifications and requirements, we consider whether the modification either creates new, or changes existing, enforceable rights and obligations. Contract modifications that are for goods or services that are not distinct from the existing contract, due to the significant integration with the original product or service provided, are accounted for as if they were part of that existing contract. The effect of a contract modification on the transaction price, and our measure of progress for the performance obligation to which it relates, is recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) under the cumulative catch-up method. When the modifications include additional performance obligations that are distinct and at a relative stand-alone selling price, they are accounted for as a new contract and performance obligation and recognized prospectively.
Warranties and Returns
For both Test & Simulation and Sensors, we provide a manufacturer's warranty on our products and systems which is included in customer contracts. For sales that include installation services, warranty obligations generally extend for a period of 12 to 24 months from the date of either shipment or acceptance based on contract terms. Product obligations generally extend 12 to 24 months from the date of purchase. Certain products offered in our Sensors segment include a lifetime warranty.
Under the terms of these warranties, we are obligated to repair or replace any components or assemblies deemed defective due to workmanship or materials. We reserve the right to reject warranty claims where it is determined that failure is due to normal wear, customer modifications, improper maintenance or misuse. At the time a sale is recognized, we record estimated future warranty costs. The percentage applied reflects our historical warranty claims experience over the preceding 12 -month period. Both the experience percentage and the warranty liability are evaluated on an ongoing basis for adequacy. Warranty provisions are also recognized for certain unanticipated product claims that are individually significant. We also offer separately-priced extended warranties or service-type contracts on certain products for which revenue is recognized over the contractual period or as services are rendered.
Our sales terms generally do not allow for a right of return except for situations where the product fails. When the right of return exists, we recognize revenue for the transferred products at the expected amount of consideration for which we will be entitled.
Shipping and Handling
Freight revenue billed to customers is reported within revenue in the Consolidated Statements of Income. Expenses incurred for shipping products to customers are reported within cost of sales in the Consolidated Statements of Income.
Pre-contract Costs
14
NOTE 4 INVENTORIES
Inventories consist of material, labor and overhead costs and are stated at the lower of cost or net realizable value determined under the first-in, first-out accounting method. Certain inventories are measured using the weighted average cost method. Inventories, net are as follows:
March 28, 2020 | September 28, 2019 | |||||||
Components, assemblies and parts | $ | $ | ||||||
Customer projects in various stages of completion | ||||||||
Finished goods | ||||||||
Total inventories, net | $ | $ | ||||||
NOTE 5 LEASES
We determine if an arrangement contains a lease at inception based on whether or not we have the right to control the asset during the contract period and other facts and circumstances. We are the lessee in a lease contract when we obtain the right to control the asset. Operating leases are included in other long-term assets, other accrued liabilities and other long-term liabilities in our Consolidated Balance Sheet. Right-of-use assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease, both of which are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Leases with a lease term of 12 months or less at inception are not recorded on our Consolidated Balance Sheet and are expensed on a straight-line basis over the lease term in our Consolidated Statement of Income. We determine the lease term by assuming the exercise of renewal options that are reasonably certain. Most leases have remaining lease terms of one to ten years , some of which include options to extend the lease terms one to five years or more.
As most of our leases do not provide an implicit interest rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The incremental borrowing rate is used in determining the present value of lease payments, unless an implicit rate is specified. When our contracts contain lease and non-lease components, we account for both components as a single lease component.
We have operating leases for facilities, vehicles and equipment. We also have financing leases for certain vehicles. Our lease agreements do not contain any material residual value guarantees, material bargain purchase options or material restrictive covenants. We have no material sublease arrangements with third parties or lease transactions with related parties.
During the three and six months ended March 28, 2020, rent expense was $2,175 and $4,993 , respectively, primarily related to operating lease costs. Costs associated with short-term leases, variable rent and subleases were immaterial.
Supplemental balance sheet information related to leases is as follows:
Classification | March 28, 2020 | September 29, 2019 | |||||||
Assets | |||||||||
Operating leases | Other long-term assets | $ | $ | ||||||
Finance leases | Other long-term assets 1 | ||||||||
Total leased assets | $ | $ | |||||||
Liabilities | |||||||||
Current | |||||||||
Operating leases | Other accrued liabilities | $ | $ | ||||||
Finance leases | Other accrued liabilities 2 | ||||||||
Non-current | |||||||||
Operating leases | Other long-term liabilities | ||||||||
Finance leases | Other long-term liabilities 2 | ||||||||
Total lease liabilities | $ | $ | |||||||
15
1 | Assets held under capital leases were reclassified from property and equipment, net to other long-term assets as part of the adoption of the new lease standard. |
2 | Finance lease obligations were reclassified from long-term debt, less current maturities, net to other accrued liabilities and other long-term liabilities as part of the adoption of the new lease standard. |
Supplemental cash flow information related to leases is as follows:
Six Months Ended | |||
March 28, 2020 | |||
Cash paid for amounts included in the measurement of lease liabilities | |||
Operating cash flows from operating leases | $ | ||
Operating cash flows from finance leases | |||
Financing cash flows from finance leases | |||
Operating leased assets obtained in exchange for new lease liabilities | $ | ||
The weighted average remaining lease terms and weighted average discount rates are as follows:
March 28, 2020 | ||
Weighted average remaining lease term | ||
Operating leases | ||
Finance leases | ||
Weighted average discount rate | ||
Operating leases | % | |
Finance leases | % | |
Future lease payments under non-cancelable leases for the next five years and thereafter are as follows:
March 28, 2020 | ||||||
Operating Leases | Finance Leases | |||||
Remainder of 2020 | $ | $ | ||||
2021 | ||||||
2022 | ||||||
2023 | ||||||
2024 | ||||||
2025 | ||||||
Thereafter | ||||||
Total lease payments | ||||||
Less imputed interest | ( | ) | ( | ) | ||
Total reported lease liability | $ | $ | ||||
As of March 28, 2020, we have no material additional operating or finance leases that have not yet commenced.
16
Future minimum lease commitments under non-cancelable leases for the next five years and thereafter were as follows:
September 28, 2019 | ||||||
Operating Leases | Capital Leases | |||||
2020 | $ | $ | ||||
2021 | ||||||
2022 | ||||||
2023 | ||||||
2024 | ||||||
Thereafter | ||||||
Total | $ | $ | ||||
NOTE 6 CAPITAL ASSETS
Property and Equipment
Property and equipment, net are as follows:
March 28, 2020 | September 28, 2019 | |||||||
Land and improvements | $ | $ | ||||||
Buildings and improvements | ||||||||
Machinery and equipment | ||||||||
Assets held under capital leases 1 | — | |||||||
Total property and equipment | ||||||||
Less: Accumulated depreciation | ( | ) | ( | ) | ||||
Total property and equipment, net | $ | $ | ||||||
1 | Assets held under capital leases were reclassified from property and equipment, net to other long-term assets as part of the adoption of the new lease standard. See Note 5 for additional information regarding leases. |
Goodwill
Changes to the carrying amount of goodwill are as follows:
Test & Simulation | Sensors | Total | ||||||||||
Balance, September 28, 2019 | $ | $ | $ | |||||||||
Acquisitions 2 | ||||||||||||
Currency translation | ||||||||||||
Balance, March 28, 2020 | $ | $ | $ | |||||||||
2 See Note 16 for additional information regarding acquisitions.
17
Intangible Assets
Intangible assets are as follows:
March 28, 2020 | ||||||||||||||
Gross Carrying Amount | Accumulated Amortization | Net Carrying Value | Weighted Average Useful Life (in Years) | |||||||||||
Software development costs 3 | $ | $ | ( | ) | $ | |||||||||
Technology and patents | ( | ) | ||||||||||||
Trademarks and trade names | ( | ) | ||||||||||||
Customer lists | ( | ) | ||||||||||||
Land-use rights | ( | ) | ||||||||||||
Other | ( | ) | ||||||||||||
Trade names | — | Indefinite | ||||||||||||
Total intangible assets | $ | $ | ( | ) | $ | |||||||||
September 28, 2019 | ||||||||||||||
Gross Carrying Amount | Accumulated Amortization | Net Carrying Value | Weighted Average Useful Life (in Years) | |||||||||||
Software development costs 3 | $ | $ | ( | ) | $ | |||||||||
Technology and patents | ( | ) | ||||||||||||
Trademarks and trade names | ( | ) | ||||||||||||
Customer lists | ( | ) | ||||||||||||
Land-use rights | ( | ) | ||||||||||||
Other | ( | ) | ||||||||||||
Trade names | — | Indefinite | ||||||||||||
Total intangible assets | $ | $ | ( | ) | $ | |||||||||
3 | The gross carrying amount of software development costs as of March 28, 2020 and September 28, 2019 includes $ |
Amortization expense recognized related to finite-lived intangible assets is as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||
Amortization expense | $ | $ | $ | $ | ||||||||||||
Assessing goodwill, indefinite-lived intangible and long-lived assets for impairment requires management to make assumptions and apply judgment, including forecasting future sales and expenses, and selecting appropriate discount rates, which can be affected by economic conditions and other factors that can be difficult to predict. We do not believe there is a reasonable likelihood that there will be a material change in the estimates or assumptions used to calculate impairment losses of goodwill, indefinite-lived intangible or long-lived assets as of the end of the second quarter of fiscal year 2020. However, if actual results are not consistent with the estimates and assumptions used in the calculations, we may be exposed to future impairment losses that could be material.
18
Estimated future amortization expense related to finite-lived intangible assets is as follows:
Amortization Expense | |||
Remainder of 2020 | $ | ||
2021 | |||
2022 | |||
2023 | |||
2024 | |||
2025 | |||
Thereafter | |||
Future amortization amounts presented above are estimates. Actual future amortization expense may be different due to fluctuations in foreign currency exchange rates, future acquisitions, impairments, changes in amortization periods or other factors.
NOTE 7 FAIR VALUE MEASUREMENTS
In determining the fair value of financial assets and liabilities, we currently utilize market data or other assumptions that we believe market participants would use in pricing the asset or liability in the principal or most advantageous market and adjust for non-performance and/or other risk associated with the company as well as counterparties, as appropriate. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
• | Level 1: Unadjusted quoted prices which are available in active markets for identical assets or liabilities accessible to us at the measurement date. |
• | Level 2: Inputs other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. |
• | Level 3: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. |
The hierarchy gives the highest priority to Level 1, as this level provides the most reliable measure of fair value, while giving the lowest priority to Level 3.
19
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Financial assets and liabilities subject to fair value measurements on a recurring basis are as follows:
March 28, 2020 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets | ||||||||||||||||
Currency contracts 1 | $ | $ | $ | $ | ||||||||||||
Cross currency swap 1 | ||||||||||||||||
Total assets | ||||||||||||||||
Liabilities | ||||||||||||||||
Currency contracts 1 | ||||||||||||||||
Contingent consideration 2 | ||||||||||||||||
Total liabilities | $ | $ | $ | $ | ||||||||||||
September 28, 2019 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets | ||||||||||||||||
Currency contracts 1 | $ | $ | $ | $ | ||||||||||||
Total assets | ||||||||||||||||
Liabilities | ||||||||||||||||
Currency contracts 1 | ||||||||||||||||
Total liabilities | $ | $ | $ | $ | ||||||||||||
1 | Based on observable market transactions of spot currency rates, forward currency rates on equivalently-termed instruments and interest rate curves, as applicable. Carrying amounts of the financial assets and liabilities are equal to the fair value. See Note 8 for additional information on derivative financial instruments. |
2 | Based on discounted cash flow analyses that included revenue estimates, probability of financial performance achievement and a discount rate. Carrying amounts of the financial assets and liabilities are equal to the fair value. See Note 16 for additional information on business acquisitions. |
Included in Level 3 fair value measurements as of March 28, 2020 was a noncurrent contingent consideration liability related to achievement of revenue and value-creating milestones associated with the acquisition of R&D entities described in Note 16. Changes to the contingent consideration are as follows:
Balance, September 28, 2019 | $ | |||
Additions | ||||
Interest accretion | ||||
Foreign currency translation | ( | ) | ||
Balance, March 28, 2020 | $ | |||
Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
We measure certain financial instruments at fair value on a nonrecurring basis. These assets primarily include goodwill, intangible assets and other long-lived assets acquired either as part of a business acquisition, individually or with a group of other assets, as well as property and equipment and right-of-use lease assets. These assets were initially measured and recognized at amounts equal to the fair value determined as of the date of acquisition or purchase subject to changes in value only for foreign currency translation. Periodically, these assets are tested for impairment by comparing their respective carrying values to the estimated fair value of the reporting unit or asset group in which they reside. In the event any of these assets were to become impaired, we would recognize an impairment loss equal to the amount by which the carrying value of the reporting unit, impaired asset or asset group exceeds its estimated fair value. Fair value measurements of reporting units are estimated using an income approach involving discounted or undiscounted cash flow models that contain certain Level 3 inputs requiring management judgment, including projections of economic conditions and customer demand, revenue and margins, changes in competition, operating costs, working capital requirements and new product introductions. Fair value measurements of the
20
reporting units associated with our goodwill balances and our indefinite-lived intangible assets are estimated at least annually in the fourth quarter of each fiscal year for purposes of impairment testing if a quantitative analysis is performed. Fair value measurements associated with our intangible assets, other long-lived assets, property and equipment and right-of-use lease assets are estimated when events or changes in circumstances such as market value, asset utilization, physical change, legal factors or other matters indicate that the carrying value may not be recoverable. See Note 6 for additional information on goodwill, indefinite-lived intangible assets, other long-lived assets and property and equipment. See Note 5 for additional information on right-of-use lease assets.
Assets and Liabilities Not Measured at Fair Value
Certain financial instruments are not measured at fair value but are recorded at carrying amounts approximating fair value based on their short-term nature or variable interest rate. These financial instruments include cash and cash equivalents, accounts receivable, unbilled accounts receivable, accounts payable and short-term borrowings.
Other Financial Instruments
Other financial instruments subject to fair value measurements include debt, which is recorded at carrying value in the Consolidated Balance Sheets. The carrying amount and estimated fair values of our debt are as follows:
March 28, 2020 | ||||||||||||||||||||
Carrying Value | Fair Value | Level 1 | Level 2 | Level 3 | ||||||||||||||||
Tranche B term loan 3 | $ | $ | $ | $ | $ | |||||||||||||||
Senior unsecured notes 3 | ||||||||||||||||||||
Total debt | $ | $ | $ | $ | $ | |||||||||||||||
September 28, 2019 | ||||||||||||||||||||
Carrying Value | Fair Value | Level 1 | Level 2 | Level 3 | ||||||||||||||||
Tranche B term loan 3 | $ | $ | $ | $ | $ | |||||||||||||||
Senior unsecured notes 3 | ||||||||||||||||||||
Total debt | $ | $ | $ | $ | $ | |||||||||||||||
3 | The fair value of the tranche B term loan and senior unsecured notes is based on the most recently quoted market price for the outstanding debt instrument, adjusted for any known significant deviations in value. The estimated fair value of the debt obligation is not necessarily indicative of the amount that would be realized in a current market exchange. See Note 9 for additional information on financing arrangements. |
NOTE 8 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
Our currency exchange contracts are designated as cash flow hedges and qualify as hedging instruments. We also have derivatives that are not designated as cash flow hedges and, therefore, are accounted for and reported under foreign currency guidance. Regardless of designation for accounting purposes, we believe all of our derivative instruments are hedges of transactional risk exposures. The fair value of our outstanding designated and undesignated derivative assets and liabilities are reported in the Consolidated Balance Sheets as follows:
March 28, 2020 | ||||||||
Prepaid Expenses and Other Current Assets | Other Accrued Liabilities | |||||||
Designated hedge derivatives | ||||||||
Cash flow derivatives | $ | $ | ||||||
Cross currency swap | ||||||||
Total designated hedge derivatives | ||||||||
Undesignated hedge derivatives | ||||||||
Balance sheet derivatives | ||||||||
Total hedge derivatives | $ | $ | ||||||
21
September 28, 2019 | ||||||||
Prepaid Expenses and Other Current Assets | Other Accrued Liabilities | |||||||
Designated hedge derivatives | ||||||||
Cash flow derivatives | $ | $ | ||||||
Total designated hedge derivatives | ||||||||
Undesignated hedge derivatives | ||||||||
Balance sheet derivatives | ||||||||
Total hedge derivatives | $ | $ | ||||||
A reconciliation of the net fair value of designated hedge derivatives subject to master netting arrangements that are recorded in the Consolidated Balance Sheets to the net fair value that could have been reported in the Consolidated Balance Sheets is as follows:
Gross Recognized Amount | Gross Offset Amount | Net Amount Presented | Derivatives Subject to Offset | Cash Collateral Received | Net Amount | |||||||||||||||||||
March 28, 2020 | ||||||||||||||||||||||||
Assets | $ | $ | $ | $ | ( | ) | $ | $ | ||||||||||||||||
Liabilities | ( | ) | ||||||||||||||||||||||
September 28, 2019 | ||||||||||||||||||||||||
Assets | $ | $ | $ | $ | ( | ) | $ | $ | ||||||||||||||||
Liabilities | ( | ) | ||||||||||||||||||||||
Currency exchange contracts utilized to maintain the functional currency value of expected financial transactions denominated in foreign currencies are designated as cash flow hedges. Gains and losses related to changes in the market value of these contracts are reported as a component of accumulated other comprehensive income (AOCI) within shareholders' equity in the Consolidated Balance Sheets and reclassified to earnings in the same line item in the Consolidated Statements of Income and in the same period as the recognition of the underlying hedged transaction. We periodically assess whether our currency exchange contracts are effective and, when a contract is determined to be no longer effective as a hedge, we discontinue hedge accounting prospectively.
As of March 28, 2020 and September 28, 2019, we had outstanding cash flow hedge currency exchange contracts with gross notional U.S. dollar equivalent amounts of $29,323 and $43,033 , respectively. Upon netting offsetting contracts to sell foreign currencies against contracts to purchase foreign currencies, irrespective of contract maturity dates, the net notional U.S. dollar equivalent amount of contracts outstanding was $28,179 and $38,177 as of March 28, 2020 and September 28, 2019, respectively. As of March 28, 2020, the net market value of the foreign currency exchange contracts was a net asset of $496 , consisting of $542 in assets and $46 in liabilities. As of September 28, 2019, the net market value of the foreign currency exchange contracts was a net asset of $774 , consisting of $907 in assets and $133 in liabilities.
The pretax amounts recognized in AOCI on currency exchange contracts, including (gains) losses reclassified into earnings in the Consolidated Statements of Income and gains (losses) recognized in other comprehensive income (loss) (OCI), are as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||
Beginning unrealized net gain (loss) in AOCI | $ | $ | $ | $ | ||||||||||||
Net (gain) loss reclassified into revenue | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Net gain (loss) recognized in OCI | ( | ) | ||||||||||||||
Ending unrealized net gain (loss) in AOCI | $ | $ | $ | $ | ||||||||||||
22
As of March 28, 2020, the amount projected to be reclassified from AOCI into earnings in the next 12 months was a net gain of $307 . The maximum remaining maturity of any forward or optional contract as of March 28, 2020 was 1.0 year.
Interest Rate Swap
On October 20, 2016, we entered into a floating to fixed interest rate swap agreement to mitigate our exposure to interest rate increases related to a portion of our tranche B term loan facility. In connection with the repayment of a portion of the tranche B term loan facility during the fourth quarter of fiscal year 2019, we terminated the interest rate swap agreement. Prior to termination, every month we paid fixed interest at 1.256 % in exchange for interest received at one month U.S. LIBOR. The interest rate swap was designated as a cash flow hedge. As a result, changes in the fair value of the interest rate swap were recorded in AOCI within shareholders' equity in the Consolidated Balance Sheets. The unrealized gains on the interest rate swap associated with the interest payments on our tranche B term loan facility that are still forecasted to occur are included in AOCI. These gains will be reclassified into interest expense over the life of the original swap agreement as the hedged interest payments occur.
The pretax amounts recognized in AOCI on the interest rate swap, including (gains) losses reclassified into earnings in the Consolidated Statements of Income and gains (losses) recognized in OCI, are as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||
Beginning unrealized net gain (loss) in AOCI | $ | $ | $ | $ | ||||||||||||
Net (gain) loss reclassified into interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Net gain (loss) recognized in OCI | ( | ) | ( | ) | ||||||||||||
Ending unrealized net gain (loss) in AOCI | $ | $ | $ | $ | ||||||||||||
As of March 28, 2020, the amount projected to be reclassified from AOCI into earnings in the next 12 months was a net gain of $542 .
Foreign Currency Balance Sheet Derivatives
We also use foreign currency derivative contracts to maintain the functional currency value of monetary assets and liabilities denominated in non-functional foreign currencies. The gains and losses related to the changes in the market value of these derivative contracts are included in other income (expense), net in the Consolidated Statements of Income.
As of March 28, 2020 and September 28, 2019, we had outstanding foreign currency balance sheet derivative contracts with gross notional U.S. dollar equivalent amounts of $73,681 and $60,827 , respectively. Upon netting offsetting contracts by counterparty banks to sell foreign currencies against contracts to purchase foreign currencies, irrespective of contract maturity dates, the net notional U.S. dollar equivalent amount of contracts outstanding as of March 28, 2020 and September 28, 2019 was $14,027 and $118 , respectively. As of March 28, 2020 and September 28, 2019, the net market value of the foreign exchange balance sheet derivative contracts was a net asset of $328 and a net liability of $118 , respectively.
The net gain (loss) recognized in the Consolidated Statements of Income on foreign exchange balance sheet derivative contracts is as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||
Net gain (loss) recognized in other income (expense), net | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
Net Investment Hedge
We have net investments in foreign subsidiaries that are subject to changes in foreign currency exchange rates. In the second quarter of fiscal year 2020, we entered into a cross-currency swap with a gross notional U.S. dollar equivalent amount of $100,485 as a net investment hedge for a portion of our net investments in our Euro denominated subsidiaries. Gains and losses resulting from a change in fair value of the net investment hedge are offset by gains and losses on the underlying foreign currency exposure and included in AOCI in our Consolidated Balance Sheets. As of March 28, 2020, the deferred foreign currency activity associated with the net investment hedge was not considered material.
23
NOTE 9 FINANCING
Long-term debt consists of the following:
March 28, 2020 | September 28, 2019 | |||||||
Long-term debt | ||||||||
Tranche B term loan, 1.00% amortizing per year, maturing July 5, 2023 | $ | $ | ||||||
Revolving credit facility, non-current portion, expiring July 5, 2023 | ||||||||
Senior unsecured notes, 5.75% coupon, maturing August 15, 2027 | ||||||||
Capital lease obligations 1 | — | |||||||
Total long-term debt | ||||||||
Less: Unamortized underwriting discounts, commissions and other expenses | ( | ) | ( | ) | ||||
Less: Current maturities of tranche B term loan debt 2, 3 | ( | ) | ( | ) | ||||
Less: Current maturities of capital lease obligations 1, 2 | — | ( | ) | |||||
Total long-term debt, less current maturities, net | $ | $ | ||||||
1 | Capital lease obligations were reclassified from long-term debt, less current maturities, net and current maturities of long-term debt, net to other accrued liabilities and other long-term liabilities in the Consolidated Balance Sheets as part of the adoption of the new lease standard in the first quarter of fiscal year 2020. See Note 5 for additional information on leases. |
2 | In addition to the current maturities above, current maturities of long-term debt, net in the Consolidated Balance Sheets includes the current portion of unamortized underwriting discounts, commissions and other expenses of $ |
3 | As of March 28, 2020 and September 28, 2019, current maturities of tranche B term loan consist of the |
Tranche B Term Loan and Revolving Credit Facility
We have a credit agreement with U.S. Bank National Association and HSBC Bank USA, National Association as Co-Documentation Agents, Wells Fargo Bank, National Association as Syndication Agent, JPMorgan Chase Bank, N.A. as Administrative Agent and JP Morgan Chase Bank, N.A. and Wells Fargo Securities, LLC as Joint Bookrunners and Joint Lead Arrangers (the Credit Agreement). The Credit Agreement as amended provides for senior secured credit facilities consisting of a $200,000 revolving credit facility (the Revolving Credit Facility) and a $460,000 tranche B term loan facility (the Term Facility) which expire on July 5, 2023. The proceeds of the Revolving Credit Facility can be drawn upon to refinance existing indebtedness, for working capital and for other general corporate purposes, up to a maximum of $200,000 . The Term Facility amortizes in equal quarterly installments equal to 1 % of the original principal amount.
In the first quarter of fiscal year 2020, we entered into a fourth amendment to the Credit Agreement to increase the borrowing capacity on the Revolving Credit Facility from $150,000 to $200,000 and extend the expiration date of the Revolving Credit Facility from July 5, 2022 to July 5, 2023. The amendment also reduced letter of credit commitments from $60,000 to $50,000 . Additionally, the required performance levels under certain financial covenants were modified. During the six months ended March 28, 2020, we incurred debt financing costs of $577 as a result of this amendment which were capitalized in prepaid and other current assets and other long-term assets in the Consolidated Balance Sheets.
The primary categories of borrowing include Alternate Base Rate (ABR) Borrowings (ABR Term Loans and ABR Revolving Loans), Swingline Loans and Eurocurrency Borrowings (Eurocurrency Term Loans and Eurocurrency Revolving Loans), each as defined in the Credit Agreement. ABR Borrowings and Swingline Loans made in U.S. dollars under the Credit Agreement bear interest at a rate per annum equal to the ABR plus the Applicable Rate (as defined in the Credit Agreement). The ABR is defined as the greater of (a) the Prime Rate (as defined in the Credit Agreement) in effect on such day, (b) the New York Federal Reserve Bank (NYFRB) rate (as defined in the Credit Agreement) in effect on such day plus ½ of 1.00%, or (c) the Adjusted LIBOR (as defined in the Credit Agreement) for a one-month interest period in dollars on such day plus 1.00 %. The ABR for ABR Term Loans shall not be less than 1.75 % per annum. The Applicable Rate for any ABR Revolving Loans will be based upon the leverage ratio applicable on such date. As of March 28, 2020, the Applicable Rate for ABR Term Loans was 2.25 % per annum.
24
Eurocurrency Borrowings made under the Credit Agreement bear interest at a rate per annum equal to the Adjusted LIBOR Rate plus the Applicable Rate. The Adjusted LIBOR Rate is defined as an interest rate per annum equal to (a) the LIBOR Rate for such interest period multiplied by (b) the Statutory Reserve Rate (as defined in the Credit Agreement). The Applicable Rate for any Eurocurrency Revolving Loan is based upon the leverage ratio applicable on such date. The Adjusted LIBOR Rate for Eurocurrency Term Loans shall not be less than 0.75 % per annum. Based on our leverage ratio as of March 28, 2020, the Applicable Rate for Eurocurrency Revolving Loans was 2.75 %. As of March 28, 2020, the Applicable Rate for Eurocurrency Term Loans was 3.25 % per annum, plus the applicable Adjusted LIBOR Rate of 1.61 %. The weighted average interest rate on Term Facility debt during the six months ended March 28, 2020 was 5.02 %.
As of March 28, 2020, there was $90,576 of outstanding borrowings under the Revolving Credit Facility which is included in short-term borrowings and long-term debt, less current maturities, net in the Consolidated Balance Sheets. As of September 28, 2019, there were no outstanding borrowings under the Revolving Credit Facility. We had outstanding letters of credit drawn from the Revolving Credit Facility totaling $13,680 and $21,173 as of March 28, 2020 and September 28, 2019, respectively, leaving approximately $95,744 and $128,827 , respectively, of unused borrowing capacity. Commitment fees are payable on the unused portion of the Revolving Credit Facility at rates between 0.20 % and 0.35 % based on our leverage ratio. During the three months ended March 28, 2020 and March 30, 2019, commitment fees incurred totaled $91 and $52 , respectively. During the six months ended March 28, 2020 and March 30, 2019, commitment fees incurred totaled $191 and $124 , respectively.
The Credit Agreement governing the Term Facility requires us to prepay outstanding term loans, subject to certain exceptions, depending on the leverage ratio with (a) up to 50 % of the our annual Excess Cash Flow (as defined in the Credit Agreement) and (b) 100 % of the net cash proceeds of (i) certain asset sales and casualty and condemnation events, subject to reinvestment rights and certain other exceptions; and (ii) any incurrence or issuance of certain debt, other than debt permitted under the Credit Agreement. We may voluntarily prepay outstanding loans under the Term Facility at any time without premium or penalty. All obligations under the Credit Agreement are unconditionally guaranteed by certain of our existing wholly-owned domestic subsidiaries, and are secured, subject to certain exceptions, by substantially all of our assets and the assets of our subsidiary guarantors.
Under the Credit Agreement, we are subject to customary affirmative and negative covenants, including, among others, restrictions on our ability to incur debt, create liens, dispose of assets, make investments, loans, advances, guarantees, and acquisitions, enter into transactions with affiliates, and enter into any restrictive agreements and customary events of default (including payment defaults, covenant defaults, change of control defaults and bankruptcy defaults). The Credit Agreement also contains financial covenants, including the ratio of consolidated total indebtedness to adjusted consolidated earnings before income, taxes, depreciation and amortization (Adjusted EBITDA), as defined in the Credit Agreement, as well as the ratio of Adjusted EBITDA to consolidated interest expense. These covenants restrict our ability to purchase outstanding shares of our common stock. As of March 28, 2020 and September 28, 2019, we were in compliance with these financial covenants.
Senior Unsecured Notes
In the fourth quarter of fiscal year 2019, we issued $350,000 in aggregate principal amount of 5.750 % senior unsecured notes due in 2027 (the Notes). The Notes were issued pursuant to an Indenture dated as of July 16, 2019 among us, the Guarantors (as defined therein) and Wells Fargo Bank, National Association, as trustee (the Indenture). The Notes will mature on August 15, 2027. Interest accrues at the rate of 5.750 % per annum and is payable semi-annually on each February 15 and August 15. We used the net proceeds after discounts and expenses of $343,352 from the offering to repay all then outstanding debt under the Revolving Credit Facility, to repay a portion of the Term Facility and for general corporate purposes.
The Notes and the guarantees constitute senior unsecured obligations of the company and the Guarantors, respectively. The Notes are: (a) equal in right of payment with all existing or future unsecured indebtedness that is not subordinated to the Notes; (b) senior in right of payment to any existing or future indebtedness that is subordinated to the Notes; (c) unconditionally guaranteed by the Guarantors; (d) effectively subordinated to all existing or future indebtedness this is secured, including borrowings under the Credit Agreement, to the extent of the value of assets securing such indebtedness; and (e) structurally subordinated to all indebtedness, other liabilities and preferred stock, of any of our subsidiaries that are not Guarantors.
The Indenture governing the Notes contains covenants that limit, among other things, our ability and the ability of our restricted subsidiaries to incur additional indebtedness or issue certain preferred shares, create liens; pay dividends, redeem stock or make other distributions; make investments; for our restricted subsidiaries to pay dividends to us or make other intercompany transfers; transfer or sell assets; merge or consolidate; enter into certain transactions with our affiliates; and designate subsidiaries as unrestricted subsidiaries. If we experience a change of control, we must offer to repurchase all of the Notes (unless otherwise redeemed) at a price equal to 101 % of the aggregate principal amount of the Notes, plus accrued and unpaid interest, if any, on such Notes to the repurchase date. If we sell assets under certain circumstances, we must use the proceeds to make an offer to repurchase all of the Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to the date of purchase.
25
See Note 7 for additional information on the fair value of the tranche B term loan and the senior unsecured notes.
NOTE 10 STOCK-BASED COMPENSATION
We compensate our officers, directors and employees with stock-based compensation under the 2017 Stock Incentive Plan (the 2017 Plan) approved by our shareholders and administered under the supervision of our Board of Directors. During the second quarter of fiscal year 2020, we registered an additional 500 shares of common stock for issuance under the 2017 Plan. As of March 28, 2020, a total of 570 shares were available for issuance under the 2017 Plan.
We make an annual stock grant under the 2017 Plan of stock options, restricted stock units and performance restricted stock units, as well as stock grants throughout the fiscal year. For fiscal years 2020, 2019 and 2018, the annual stock grant occurred in December 2019, December 2018 and April 2018, respectively.
Stock Options
During the six months ended March 28, 2020, 274 stock options were granted at a weighted average fair value of $9.31 . During the six months ended March 30, 2019, 231 stock options were granted at a weighted average fair value of $9.91 .
Restricted Stock Units and Performance Restricted Stock Units
We award restricted stock units to directors and key employees and performance restricted stock units to key employees. During the six months ended March 28, 2020, we granted 133 restricted stock units and 53 performance restricted stock units to directors, officers and employees. During the six months ended March 30, 2019, we granted 124 restricted stock units and 40 performance restricted stock units. The fair value of the restricted stock units and performance restricted stock units granted during the six months ended March 28, 2020 and March 30, 2019 was $43.54 and $46.45 , respectively, representing the market value of our shares as of the date of grant less the present value of estimated foregone dividends over the vesting period.
Employee Stock Purchase Plan
NOTE 11 INCOME TAXES
The Tax Cuts and Jobs Act (the Tax Act) was enacted into law on December 22, 2017 and made significant changes to U.S. federal corporate tax law. Effective January 1, 2018, the Tax Act lowered the U.S. corporate tax rate from 35% to 21% and prompted various other changes to U.S. federal corporate tax law, including the establishment of a territorial-style system for taxing foreign-source income of domestic multinational corporations and a one-time deemed repatriation tax on untaxed foreign earnings.
Generally, the impacts of new tax legislation would be required to be recorded in the period of enactment, which was our first quarter of fiscal year 2018. However, in March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118, which incorporates various SEC paragraphs from Staff Accounting Bulletin No. 118 into income tax accounting guidance effective immediately, allowing registrants to record provisional amounts during a one-year measurement period.
The effective tax rate for the six months ended March 28, 2020 increased primarily due to certain discrete benefits in the prior year for the estimated impact of the Tax Act, as well as a discrete tax expense of $382 in the current year related to foreign taxes that are not creditable in the U.S. Excluding the impact of certain discrete items in both fiscal years, the effective tax rate for the six months ended March 28, 2020 decreased compared to the same prior year period primarily due to a decrease in earnings.
As of December 29, 2018, we completed our accounting for the tax effects of the Tax Act at the conclusion of the one-year measurement period. As a result, the income tax provision for the six months ended March 30, 2019 includes certain discrete benefits of $1,293 for Tax Act measurement period adjustments. The discrete benefits relate to $1,297 of additional dividends received deduction for certain foreign tax credits included in the mandatory deemed repatriation tax calculation, partially offset by $4 of expense for other Tax Act measurement period adjustments. The additional dividends received deduction is based on our assessment of the treatment under the applicable provisions of the Tax Act as written and enacted during the first quarter of fiscal year 2019. The Department of the Treasury provided regulatory updates during the three months ended June 29, 2019, causing us to change our assessment of the benefit associated with the dividends received deduction, and in the third quarter of fiscal year 2019 to reverse the entire benefit of $1,297 that was recorded in the first quarter of fiscal year 2019.
26
As of March 28, 2020, the liability for unrecognized tax benefits was $4,985 , of which $3,332 would favorably affect our effective tax rate, if recognized. As of September 28, 2019, the liability for unrecognized tax benefits was $4,414 , of which $2,761 would favorably affect our effective tax rate, if recognized. As of March 28, 2020, we do not expect significant changes in the amount of unrecognized tax benefits during the next twelve months.
NOTE 12 EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per share is computed by dividing net income (loss) by the daily weighted average number of common shares outstanding during the applicable period. For the three and six months ended March 30, 2019, the tangible equity units (TEUs) were assumed to be settled at the minimum settlement amount of 1.9841 shares per TEU when calculating weighted-average common shares outstanding for purposes of basic earnings (loss) per share.
Using the treasury stock method, diluted earnings (loss) per share includes the potentially dilutive effect of common shares issued in connection with outstanding stock-based compensation options and grants. The potentially dilutive effect of common shares issued in connection with outstanding stock options is determined based on the average market price for the period. For the three and six months ended March 30, 2019 diluted earnings per share, the TEUs were assumed to be settled at a conversion factor based on our daily volume-weighted average price per share of our common stock for the 20 consecutive trading days preceding the end of the current fiscal quarter not to exceed 2.3810 shares of common stock per TEU.
Under the treasury stock method, shares associated with certain stock options have been excluded from the diluted weighted average shares outstanding calculation because the exercise of those options would lead to a net reduction in common shares outstanding or anti-dilution. As a result, stock options to acquire 1,230 and 865 weighted common shares have been excluded from the diluted weighted average common shares outstanding calculation for the three months ended March 28, 2020 and March 30, 2019, respectively. Stock options to acquire 984 and 791 weighted common shares have been excluded from the diluted weighted average common shares outstanding calculation for the six months ended March 28, 2020 and March 30, 2019, respectively.
In connection with the pricing of the TEUs, we purchased capped calls. For the three and six months ended March 30, 2019, the capped calls were not reflected in the calculation of diluted earnings per share as they had not yet settled and, therefore, led to a net reduction in common shares outstanding or anti-dilution. The capped calls were settled in the fourth quarter of fiscal year 2019 in conjunction with the settlement of the TEUs.
Basic and diluted earnings (loss) per share are calculated as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||
Net income (loss) | $ | ( | ) | $ | $ | $ | ||||||||||
Weighted average common shares outstanding | ||||||||||||||||
Effect of dilutive securities | ||||||||||||||||
Stock-based compensation | ||||||||||||||||
Weighted average dilutive common shares outstanding | ||||||||||||||||
Earnings (loss) per share | ||||||||||||||||
Basic | $ | ( | ) | $ | $ | $ | ||||||||||
Diluted | ( | ) | ||||||||||||||
27
NOTE 13 OTHER COMPREHENSIVE INCOME (LOSS)
Other comprehensive income (loss), a component of shareholders' equity, consists of foreign currency translation adjustments, gains or losses on derivative instruments and defined benefit pension plan adjustments.
Income tax expense or benefit allocated to each component of other comprehensive income (loss) is as follows:
Three Months Ended | Six Months Ended | |||||||||||||||||||||||
March 28, 2020 | ||||||||||||||||||||||||
Pre-tax | Tax | Net | Pretax | Tax | Net | |||||||||||||||||||
Foreign currency translation gain (loss) adjustments | $ | ( | ) | $ | — | $ | ( | ) | $ | $ | — | $ | ||||||||||||
Derivative instruments | ||||||||||||||||||||||||
Unrealized net gain (loss) | ( | ) | ( | ) | ||||||||||||||||||||
Net (gain) loss reclassified to earnings | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Defined benefit pension plan | ||||||||||||||||||||||||
Unrealized net gain (loss) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Net (gain) loss reclassified to earnings | ( | ) | ( | ) | ||||||||||||||||||||
Currency exchange rate gain (loss) | — | ( | ) | — | ( | ) | ||||||||||||||||||
Other comprehensive income (loss) | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||
March 30, 2019 | ||||||||||||||||||||||||
Pre-tax | Tax | Net | Pretax | Tax | Net | |||||||||||||||||||
Foreign currency translation gain (loss) adjustments | $ | ( | ) | $ | — | $ | ( | ) | $ | ( | ) | $ | — | $ | ( | ) | ||||||||
Derivative instruments | ||||||||||||||||||||||||
Unrealized net gain (loss) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Net (gain) loss reclassified to earnings | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Defined benefit pension plan | ||||||||||||||||||||||||
Unrealized net gain (loss) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Net (gain) loss reclassified to earnings | ( | ) | ( | ) | ||||||||||||||||||||
Currency exchange rate gain (loss) | — | — | ||||||||||||||||||||||
Other comprehensive income (loss) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||||
The changes in the net-of-tax balances of each component of AOCI are as follows:
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||||
March 28, 2020 | ||||||||||||||||||||||||||||||||
Adjustments | Adjustments | |||||||||||||||||||||||||||||||
Foreign Currency Translation | Unrealized Derivative Instrument | Defined Benefit Pension Plan | Total | Foreign Currency Translation | Unrealized Derivative Instrument | Defined Benefit Pension Plan | Total | |||||||||||||||||||||||||
Beginning balance | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
Other comprehensive net gain (loss) reclassifications | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||
Net (gain) loss reclassified to earnings | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||
Other comprehensive income (loss) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||
Ending balance | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
28
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||||
March 30, 2019 | ||||||||||||||||||||||||||||||||
Adjustments | Adjustments | |||||||||||||||||||||||||||||||
Foreign Currency Translation | Unrealized Derivative Instrument | Defined Benefit Pension Plan | Total | Foreign Currency Translation | Unrealized Derivative Instrument | Defined Benefit Pension Plan | Total | |||||||||||||||||||||||||
Beginning balance | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||||||||||
Other comprehensive net gain (loss) reclassifications | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Net (gain) loss reclassified to earnings | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||
Other comprehensive income (loss) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Ending balance | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
The effect on certain line items in the Consolidated Statements of Income of amounts reclassified out of AOCI are as follows:
Three Months Ended | Six Months Ended | Affected Line Item in the Consolidated Statements of Income | ||||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||||
Derivative instruments | ||||||||||||||||||
Currency exchange contracts gain (loss) | $ | $ | $ | $ | Revenue | |||||||||||||
Interest rate swap contracts gain (loss) | Interest expense, net | |||||||||||||||||
Income tax benefit (expense) | ( | ) | ( | ) | ( | ) | ( | ) | Income tax provision (benefit) | |||||||||
Total net gain (loss) on derivative instruments | Net income (loss) | |||||||||||||||||
Defined benefit pension plan | ||||||||||||||||||
Actuarial loss | ( | ) | ( | ) | ( | ) | ( | ) | Other income (expense), net | |||||||||
Income tax benefit | Income tax provision (benefit) | |||||||||||||||||
Total net loss on pension plan | ( | ) | ( | ) | ( | ) | ( | ) | Net income (loss) | |||||||||
Total net of tax reclassifications out of AOCI included in net income | $ | $ | $ | $ | ||||||||||||||
NOTE 14 BUSINESS SEGMENT INFORMATION
Our Chief Executive Officer (the Chief Operating Decision Maker) regularly reviews financial information for our two reportable segments, Test & Simulation and Sensors. Test & Simulation manufactures and sells equipment and related software and services which are used by customers to characterize a product's mechanical properties or performance or create a desired human experience. Sensors manufactures and sells high-performance sensors which provide measurements of vibration, pressure, position, force and sound in a variety of applications.
In evaluating each segment's performance, our Chief Executive Officer focuses on income from operations. This measure excludes interest income and expense, income taxes and other non-operating items. Corporate expenses, including costs associated with various support functions such as human resources, information technology, legal, finance and accounting, and general and administrative costs are allocated to the reportable segments on the basis of revenue. The accounting policies of the reportable segments are the same as those described in Note 1 and Note 3 to the Consolidated Financial Statements found in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019.
Intersegment revenue is based on standard costs with reasonable mark-ups established between the reportable segments. All significant intersegment amounts are eliminated to arrive at consolidated financial results.
29
Financial information by reportable segment is as follows:
Three Months Ended | Six Months Ended | |||||||||||||||
March 28, 2020 | March 30, 2019 | March 28, 2020 | March 30, 2019 | |||||||||||||
Revenue | ||||||||||||||||
Test & Simulation | $ | $ | $ | $ | ||||||||||||
Sensors | ||||||||||||||||
Intersegment eliminations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Total revenue | $ | $ | $ | $ | ||||||||||||
Income from operations | ||||||||||||||||
Test & Simulation1 | $ | ( | ) | $ | $ | $ | ||||||||||
Sensors | ||||||||||||||||
Intersegment eliminations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Total income from operations 1 | $ | $ | $ | $ | ||||||||||||
1 |
NOTE 15 RESTRUCTURING AND RELATED COSTS
Fiscal Year 2020 Restructuring
In the second quarter of fiscal year 2020, we initiated a series of global workforce reductions and facility closures, including the reorganization of our European operations within Test & Simulation intended to increase organizational effectiveness, gain operational efficiencies and provide cost savings that can be reinvested in our growth initiatives. As a result, during the second quarter of fiscal year 2020, we recorded $6,138 of pre-tax severance and related expense. In fiscal years 2020 and 2021, we expect to incur a total of approximately $7,000 to $10,600 of pre-tax severance and related expense and facility closure costs related to these actions. No cash outlay was required in the second quarter of fiscal year 2020. The majority of the expenses are expected to be paid in the first half of fiscal year 2021.
Restructuring expenses included in the Consolidated Statements of Income are as follows:
Three and Six Months Ended | ||||
March 28, 2020 | ||||
Test & Simulation | ||||
Cost of sales | $ | |||
General and administrative | ||||
Total restructuring expense | $ | |||
Restructuring expense accruals included in accrued payroll and related costs in the Consolidated Balance Sheets for the above restructuring action are as follows:
Test & Simulation | ||||
Balance, September 28, 2019 | $ | |||
Restructuring expense | ||||
Balance, March 28, 2020 | $ | |||
NOTE 16 BUSINESS ACQUISITIONS
Acquisition of R&D Entities
Effective December 31, 2019, we completed the acquisition of R&D Test Systems, R&D Engineering, R&D Steel, R&D Prague, RGDK Engineering Private Limited and R&D Tools and Structures (collectively, R&D) for an upfront cash purchase
30
price of $58,280 . The acquisition was primarily funded through our existing Revolving Credit Facility. The remaining purchase price is based on earn-out payments of up to an additional $26,000 contingent on financial performance through June 2021. As of the acquisition date, we estimated the fair value of the earn-out liability (contingent consideration) to be $17,447 . Based out of Denmark, R&D is a leader in high-quality, durable, rotating test systems, serving primarily the wind energy markets. During the three and six months ended March 28, 2020, we included $14,708 of revenue from R&D in our Consolidated Statements of Income. Costs of $1,340 associated with the acquisition of R&D were expensed as incurred. Pro forma information related to the acquisition of R&D has not been included as the impact on our consolidated results of operations was not considered material.
The following table summarizes the preliminary fair value measurement of the assets acquired as of the date of acquisition:
Fair Value | Finite-Lived Intangible Asset Lives (Years) | ||||
Asset (Liability) | |||||
Accounts receivable | $ | ||||
Unbilled accounts receivable | |||||
Inventories | |||||
Prepaid expenses and other current assets | |||||
Property and equipment | |||||
Intangible assets | |||||
Customer lists | |||||
Trademarks and trade names | |||||
Technology | |||||
Other intangible assets | |||||
Other long-term assets | |||||
Purchased goodwill | |||||
Accounts payable | ( | ) | |||
Accrued payroll and related costs | ( | ) | |||
Advanced payments from customers | ( | ) | |||
Accrued income taxes | ( | ) | |||
Other accrued liabilities | ( | ) | |||
Deferred income taxes | ( | ) | |||
Other long-term liabilities | ( | ) | |||
Net assets acquired | $ | ||||
Supplemental information | |||||
Consideration paid at closing | $ | ||||
Estimated contingent consideration | |||||
Less: Cash acquired | ( | ) | |||
Purchase price, net of cash acquired | $ | ||||
The allocation of purchase price consideration is considered preliminary as of March 28, 2020 with provisional amounts related to accounts receivable, unbilled accounts receivable, property and equipment, intangible assets, accounts payable, advanced payments from customers, accrued income taxes, other accrued liabilities, deferred income taxes and purchase price adjustments included, which includes the contingent consideration, as our allocation process has not been finalized. We expect to finalize the allocation of purchase price as soon as possible, but no later than one year from the acquisition date.
Goodwill was calculated as the difference between the acquisition date fair value of the total purchase price consideration and the fair value of the net assets acquired and represents the future economic benefits that we expect to achieve as a result of the acquisition. This resulted in a purchase price in excess of the fair value of identifiable assets acquired. The purchase price also included the fair value of other assets that were not identifiable, not separately recognizable under accounting rules (e.g.,
31
assembled workforce) or of immaterial value. All of the goodwill was assigned to Test & Simulation. No ne of the goodwill is deductible for income tax purposes.
The fair value of the acquired intangible assets was $42,094 . The acquired intangible assets are being amortized on a straight-line basis over the useful lives identified in the table above.
Endevco Acquisition
On August 5, 2019, we acquired the Endevco sensors business (Endevco) from Meggitt PLC for a cash purchase price of $68,330 . We funded the acquisition of Endevco through cash on hand. Endevco is a historic leader in high performance test and measurement sensors used primarily in the testing of new products. This strategic product line purchase brings together two iconic brands in the test and measurement sensors market, in PCB and Endevco, and further enhances our long-term strategy of growth and market leadership in our core businesses. The transaction was accounted for under the acquisition method of accounting. The acquired assets and operating results have been included in our financial statements within Sensors from the date of acquisition. During the three and six months ended March 28, 2020, we included approximately $4,200 and $7,500 , respectively, of revenue from Endevco in our Consolidated Statements of Income. Pro forma information related to the acquisition of Endevco has not been included as the impact on our consolidated results of operations was not considered material.
The following table summarizes the preliminary fair value measurement of the assets acquired as of the date of acquisition:
Fair Value | Finite-Lived Intangible Asset Lives (Years) | ||||
Asset | |||||
Inventories | $ | ||||
Property and equipment | |||||
Intangible assets | |||||
Customer lists | |||||
Trademarks and trade names | |||||
Technology | |||||
Purchased goodwill | |||||
Deferred income taxes | |||||
Net assets acquired | $ | ||||
Supplemental information | |||||
Consideration paid at closing | $ | ||||
Post-closing purchase price adjustment | ( | ) | |||
Purchase price | $ | ||||
The fair value measurement was completed as of March 28, 2020. Measurement period adjustments were recorded in fiscal year 2020 and have been reflected in the table above. The measurement period adjustments were not material.
Goodwill was calculated as the difference between the acquisition date fair value of the total purchase price consideration and the fair value of the net assets acquired and represents the future economic benefits that we expect to achieve as a result of the acquisition. This resulted in a purchase price in excess of the fair value of identifiable assets acquired. The purchase price also included the fair value of other assets that were not identifiable, not separately recognizable under accounting rules (e.g., assembled workforce) or of immaterial value. All of the goodwill was assigned to Sensors. All of the goodwill is deductible for income tax purposes.
The fair value of the acquired intangible assets was $25,700 . The acquired intangible assets are being amortized on a straight-line basis over the useful lives identified in the table above.
32
E2M Technologies B.V. Acquisition
On November 21, 2018, we acquired all ownership interests of E2M Technologies B.V. (E2M) for a cash purchase price of $80,287 . Based in Amsterdam, Netherlands, E2M is a leading manufacturer of high force, electrically driven actuation systems, serving primarily the human-rated entertainment and training simulation markets. The acquisition of E2M expands our technology and product offerings for human-rated simulation systems and brings key regulatory approvals and customers in the flight simulation and entertainment markets. The transaction was accounted for under the acquisition method of accounting. The acquired assets, liabilities and operating results have been included in our financial statements within Test & Simulation from the date of acquisition. During fiscal year 2019, we included $29,554 of revenue from E2M in our Consolidated Statements of Income. We funded the acquisition of E2M primarily with borrowings on our Revolving Credit Facility. Costs of $1,287 associated with the acquisition of E2M were expensed as incurred. Pro forma information related to the acquisition of E2M has not been included as the impact on our consolidated results of operations was not considered material.
The following table summarizes the fair value measurement of the assets acquired and liabilities assumed, net of cash acquired, as of the date of acquisition:
Fair Value | Finite-Lived Intangible Asset Lives (Years) | ||||
Asset (Liability) | |||||
Accounts receivable | $ | ||||
Unbilled accounts receivable | |||||
Inventories | |||||
Prepaid expenses and other current assets | |||||
Property and equipment | |||||
Intangible assets | |||||
Customer lists | |||||
Trademarks and trade names | |||||
Technology | |||||
Other intangible assets | |||||
Other long-term assets | |||||
Purchased goodwill | |||||
Accounts payable | ( | ) | |||
Accrued payroll and related costs | ( | ) | |||
Advance payments from customers | ( | ) | |||
Accrued income taxes | ( | ) | |||
Other accrued liabilities | ( | ) | |||
Deferred income taxes | ( | ) | |||
Net assets acquired | $ | ||||
Supplemental information | |||||
Consideration paid at closing | $ | ||||
Post-closing purchase price adjustment | |||||
Less: Cash acquired | ( | ) | |||
Purchase price, net of cash acquired | $ | ||||
The fair value measurement was completed as of September 28, 2019. Measurement period adjustments were recorded in fiscal year 2019 and have been reflected in the table above. The measurement period adjustments were not material.
Goodwill was calculated as the difference between the acquisition date fair value of the total purchase price consideration and the fair value of the net assets acquired and represents the future economic benefits that we expect to achieve as a result of the acquisition. This resulted in a purchase price in excess of the fair value of identifiable net assets acquired. The purchase price also included the fair value of other assets that were not identifiable, not separately recognizable under accounting rules (e.g.,
33
assembled workforce) or of immaterial value. All of the goodwill was assigned to Test & Simulation. No ne of the goodwill is deductible for income tax purposes.
The fair value of the acquired intangible assets was $43,989 . The acquired intangible assets are being amortized on a straight-line basis over the useful lives identified in the table above.
NOTE 17 RISKS AND UNCERTAINTIES
Coronavirus 2019 (COVID-19) Pandemic
The global spread of COVID-19 has created significant volatility, uncertainty and economic disruption. As an essential critical infrastructure business, we have continued to operate in the U.S. and plan to continue to operate in other parts of the world as permitted. Restrictions on our employees' ability to access our customers and the temporary closures of our facilities or the facilities of our customers negatively impacted our sales and operating results for the second quarter of fiscal year 2020. We anticipate these challenges to continue to negatively impact our fiscal year 2020 revenue and operating results. The future impact COVID-19 will have on our business, operations and financial results is unknown at this time, and we are unable to accurately quantify the impact due to the significant global economic uncertainty.
The extent to which COVID-19 impacts our business, operations and financial results will depend on numerous evolving factors that we may or may not be able to accurately predict, including: the duration and scope of the pandemic; governmental, business and individuals actions that have been and continue to be taken in response to the pandemic; the impact of the pandemic on economic activity and actions taken in response; the effect on our customers' demand for our goods and services; our vendors' ability to supply us with raw materials; our ability to sell and provide our goods and services amidst travel restrictions; the ability of our customers to pay for our goods and services; and any further closures of our facilities or the facilities of our customers. Customers may also slow down decision-making, delay planned work or seek to terminate existing agreements. Any of these events could materially adversely affect our business, financial condition, results of operations and/or stock price.
In response to COVID-19 and the economic uncertainty, we continue to right-size our operations and manage short-term business risk to allow for bottom-line improvement through the execution of cost savings initiatives. We have taken actions to manage and reduce operating costs and further enhance our financial flexibility, including a temporary reduction by Dr. Jeffrey Graves of his salary by 20 %; a temporary reduction by senior executives of their salaries by 10 % to at least 15 %; a temporary reduction by non-employee directors of their cash compensation by 20 %; a reduction in workforce in connection with a global restructuring effort in our Test & Simulation business unit being executed in specifically targeted areas, including the reorganization of our European operations; other reductions in salaries or work schedules and temporary furloughs for employees, targeted toward specific, short-term impacted areas within each business unit; and reduction in all discretionary spending, capital expenditures and a strong focus on working capital management. We have also suspended our quarterly dividend of $0.30 per share, equating to approximately $23 million in annualized cash payments, which will enable us to maximize our liquidity for the foreseeable future as we face uncertain economic times.
34
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a reader of our financial statements with a narrative from the perspective of management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Our MD&A is presented in nine sections:
• | Overview |
• | Financial Results |
• | Cash Flow Comparison |
• | Liquidity and Capital Resources |
• | Off-balance Sheet Arrangements |
• | Critical Accounting Policies |
• | Recently Issued Accounting Pronouncements |
• | Other Matters |
• | Forward-looking Statements |
Our MD&A should be read in conjunction with the Consolidated Financial Statements and related Notes included in Item 1 of Part I of this Quarterly Report on Form 10-Q. All dollar and share amounts are in thousands, unless otherwise noted.
Overview
Our testing and simulation hardware, software and service solutions simulate real world environments in other than real world settings thereby enabling customers to improve design, development and manufacturing processes, determine the mechanical behavior of materials, products and structures, or create a desired human experience such as amusement rides, vehicle simulators or flight training simulators. Our high-performance sensors provide measurements of vibration, pressure, position, force and sound in a variety of applications.
Further globalization and expansion of many industries along with growth in emerging markets, such as China and India, provide a strong and vibrant market base from which we can grow revenue. We have aligned our organizational structure to be more flexible to the demands of globalized and volatile markets by adjusting our structure to be more cost effective and nimble in responding to our customers' needs. We continue to deliver distinctive business performance through our commitment to sustain the differentiated competitive advantage that comes from offering an innovative portfolio of Test & Simulation and Sensor solutions that create value for customers, delivered with total customer satisfaction.
Coronavirus 2019 (COVID-19) Pandemic
The global spread of COVID-19 has created significant volatility, uncertainty and economic disruption. As an essential critical infrastructure business, we have continued to operate in the U.S. and plan to continue to operate in other parts of the world as permitted. Restrictions on our employees’ ability to access our customers and the temporary closures of our facilities or the facilities of our customers negatively impacted our sales and operating results for the second quarter of fiscal year 2020. We anticipate these challenges to continue to negatively impact our fiscal year 2020 revenue and operating results. The future impact COVID-19 will have on our business, operations and financial results is unknown at this time, and we are unable to accurately quantify the impact due to the significant global economic uncertainty. In response, we continue to right-size our operations and manage short-term business risk to allow for bottom-line improvement through the execution of cost savings initiatives previously discussed. See Note 17 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for further discussion of COVID-19.
Acquisition
Effective December 31, 2019, we acquired R&D for an upfront cash purchase price of $58,280 primarily funded through our existing Revolving Credit Facility. The remaining purchase price is based on earn-out payments of up to an additional $26,000 contingent on financial performance through June 2021. See Note 16 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for further discussion of the acquisition of R&D.
Restructuring Initiative
In the second quarter of fiscal year 2020, we initiated a series of global workforce reductions and facility closures, including the reorganization of our European operations within Test & Simulation intended to increase organizational effectiveness, gain operational efficiencies and provide cost savings that can be reinvested in our growth initiatives. As a result, during the second quarter of fiscal year 2020, we recorded $6,138 of pre-tax severance and related expense. See Note 15 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for further discussion of restructuring initiatives.
35
Foreign Currency
Over the past 15 years, approximately 70% of our revenue has been derived from customers outside of the U.S. Our financial results are principally exposed to changes in exchange rates between the U.S. dollar and the Euro, the Japanese yen and the Chinese yuan. A change in foreign exchange rates could positively or negatively affect our reported financial results. The discussion below quantifies the impact of foreign currency translation on our financial results for the periods discussed.
Terms
The terms "MTS," "we," "us," "the Company" or "our" in this Quarterly Report on Form 10-Q, unless the context otherwise requires, refer to MTS Systems Corporation and its wholly owned subsidiaries.
Financial Results
Total Company
Results of Operations
The following tables compare results of operations, separately identifying the estimated impact of currency translation, the acquisition of R&D in the second quarter of fiscal year 2020, restructuring costs incurred in the second quarter of fiscal year 2020 and acquisition-related costs associated with Endevco incurred in fiscal year 2020.
Three Months Ended | ||||||||||||||||||||
Estimated | ||||||||||||||||||||
March 28, 2020 | Business Change | Acquisition / Restructuring1 | Currency Translation | March 30, 2019 | ||||||||||||||||
Revenue | $ | 211,463 | $ | (34,058 | ) | $ | 14,708 | $ | (2,233 | ) | $ | 233,046 | ||||||||
Cost of sales | 140,222 | (18,638 | ) | 14,918 | (1,754 | ) | 145,696 | |||||||||||||
Gross profit | 71,241 | (15,420 | ) | (210 | ) | (479 | ) | 87,350 | ||||||||||||
Gross margin | 33.7 | % | 37.5 | % | ||||||||||||||||
Operating expenses | ||||||||||||||||||||
Selling and marketing | 30,131 | (3,339 | ) | 429 | (354 | ) | 33,395 | |||||||||||||
General and administrative | 25,997 | (2,764 | ) | 6,770 | (114 | ) | 22,105 | |||||||||||||
Research and development | 7,143 | (496 | ) | — | (37 | ) | 7,676 | |||||||||||||
Total operating expenses | 63,271 | (6,599 | ) | 7,199 | (505 | ) | 63,176 | |||||||||||||
Income from operations | $ | 7,970 | $ | (8,821 | ) | $ | (7,409 | ) | $ | 26 | $ | 24,174 | ||||||||
Six Months Ended | ||||||||||||||||||||
Estimated | ||||||||||||||||||||
March 28, 2020 | Business Change | Acquisition / Restructuring1 | Currency Translation | March 30, 2019 | ||||||||||||||||
Revenue | $ | 417,306 | $ | (29,626 | ) | $ | 14,708 | $ | (4,003 | ) | $ | 436,227 | ||||||||
Cost of sales | 269,456 | (13,624 | ) | 15,458 | (2,950 | ) | 270,572 | |||||||||||||
Gross profit | 147,850 | (16,002 | ) | (750 | ) | (1,053 | ) | 165,655 | ||||||||||||
Gross margin | 35.4 | % | 38.0 | % | ||||||||||||||||
Operating expenses | ||||||||||||||||||||
Selling and marketing | 62,850 | (2,455 | ) | 429 | (608 | ) | 65,484 | |||||||||||||
General and administrative | 47,690 | (3,763 | ) | 8,516 | (246 | ) | 43,183 | |||||||||||||
Research and development | 14,182 | (594 | ) | — | (72 | ) | 14,848 | |||||||||||||
Total operating expenses | 124,722 | (6,812 | ) | 8,945 | (926 | ) | 123,515 | |||||||||||||
Income from operations | $ | 23,128 | $ | (9,190 | ) | $ | (9,695 | ) | $ | (127 | ) | $ | 42,140 | |||||||
36
1 | The Acquisition / Restructuring column includes operating results and costs incurred as part of the acquisition of R&D, costs incurred as part of the acquisition of Endevco and $6,138 of restructuring costs. Endevco operating results are not separately identifiable as Endevco has been integrated into the existing Sensors business. See Note 15 and Note 16 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information on restructuring and related costs and the R&D acquisition, respectively. |
Revenue | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Revenue | $ | 211,463 | $ | 233,046 | $ | (21,583 | ) | (9.3 | )% | $ | 417,306 | $ | 436,227 | $ | (18,921 | ) | (4.3 | )% | ||||||||||||
Revenue for the three and six months ended March 28, 2020 declined 9.3% and 4.3%, respectively, primarily driven by a decline in Test & Simulation and the unfavorable impact of currency translation, partially offset by growth in Sensors.
Test & Simulation revenue for the three and six months ended March 28, 2020 decreased $25,535 and $30,365, respectively, primarily driven by lower volume from weakness in our ground vehicles and materials sectors and service, which were negatively impacted by COVID-19, and the unfavorable impact of currency translation. The decline was partially offset by contributions from the acquisition of R&D of $14,708 and volume growth in our structures sector.
Sensors revenue for the three and six months ended March 28, 2020 increased $3,823 and $11,408, respectively, primarily driven by growth in the Sensors test sector from a multi-year contract with the U.S. Department of Defense and contributions from the Endevco acquisition, partially offset by weakness in the other three Sensors sectors driven largely by COVID-19 and the unfavorable impact of currency translation.
Excluding the impact of currency translation and the R&D acquisition, Total Company revenue decreased 14.6% and 6.8%, respectively.
Gross Profit | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Gross profit | $ | 71,241 | $ | 87,350 | $ | (16,109 | ) | (18.4 | )% | $ | 147,850 | $ | 165,655 | $ | (17,805 | ) | (10.7 | )% | ||||||||||||
Gross margin | 33.7 | % | 37.5 | % | (3.8 | ) | ppts | 35.4 | % | 38.0 | % | (2.6 | ) | ppts | ||||||||||||||||
Gross profit for the three and six months ended March 28, 2020 declined 18.4% and 10.7%, respectively, primarily driven by lower revenue volume in Test & Simulation, restructuring costs of $3,868, the unfavorable impact of Endevco integration activities and the unfavorable impact of currency translation, partially offset by lower compensation expense.
Gross margin decreased 3.8 and 2.6 percentage points, respectively, primarily due to restructuring costs and lower gross margin contribution from product mix in both Test & Simulation and Sensors, partially offset by lower compensation expense in Test & Simulation. Excluding the impact of currency translation, R&D expenses, restructuring costs and the inventory acquisition adjustment in both fiscal years, gross profit declined 18.2% and 10.2% and gross margin declined 1.6 and 1.4 percentage points, respectively.
Selling and Marketing Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Selling and marketing | $ | 30,131 | $ | 33,395 | $ | (3,264 | ) | (9.8 | )% | $ | 62,850 | $ | 65,484 | $ | (2,634 | ) | (4.0 | )% | ||||||||||||
% of revenue | 14.2 | % | 14.3 | % | 15.1 | % | 15.0 | % | ||||||||||||||||||||||
Selling and marketing expense for the three months ended March 28, 2020 declined 9.8% primarily due to lower compensation expense in Test & Simulation, lower commission expense and the favorable impact of currency translation, partially offset by the addition of R&D expenses. Excluding the impact of currency translation, R&D expenses and acquisition-related expenses in the current fiscal year, selling and marketing expense decreased 10.0%.
37
Selling and marketing expense for the six months ended March 28, 2020 declined 4.0% primarily due to lower compensation expense in Test & Simulation, lower commission expense and the favorable impact of currency translation, partially offset by higher compensation from headcount additions to support sales growth in Sensors and the addition of R&D expenses. Excluding the impact of currency translation, R&D expenses and acquisition-related expenses in the current fiscal year, selling and marketing expense decreased 3.7%.
General and Administrative Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
General and administrative | $ | 25,997 | $ | 22,105 | $ | 3,892 | 17.6 | % | $ | 47,690 | $ | 43,183 | $ | 4,507 | 10.4 | % | ||||||||||||||
% of revenue | 12.3 | % | 9.5 | % | 11.4 | % | 9.9 | % | ||||||||||||||||||||||
General and administrative expense for the three months ended March 28, 2020 increased 17.6% primarily due to R&D and Endevco acquisition-related expenses of $1,414, the addition of R&D expenses, restructuring costs of $2,270 and higher compensation expense in Sensors, partially offset by lower compensation expense in Test & Simulation and E2M acquisition-related expenses of $186, in the prior year. Excluding the impact of currency translation, R&D expenses, restructuring costs and acquisition-related expenses incurred in both fiscal years, general and administrative expense decreased 11.8%.
General and administrative expense for the six months ended March 28, 2020 increased 10.4% primarily due to R&D and Endevco acquisition-related expenses of $3,160, the addition of R&D expenses, restructuring costs of $2,270 and higher compensation expense in Sensors, partially offset by lower compensation expense in Test & Simulation and E2M acquisition-related expenses of $947 in the prior year. Excluding the impact of currency translation, R&D expenses, restructuring costs and acquisition-related expenses incurred in both fiscal years, general and administrative expense decreased 6.7%.
Research and Development Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Research and development | $ | 7,143 | $ | 7,676 | $ | (533 | ) | (6.9 | )% | $ | 14,182 | $ | 14,848 | $ | (666 | ) | (4.5 | )% | ||||||||||||
% of revenue | 3.4 | % | 3.3 | % | 3.4 | % | 3.4 | % | ||||||||||||||||||||||
Research and development expense for the three and six months ended March 28, 2020 declined 6.9% and 4.5%, respectively, primarily due to the shift of internal resources to larger, capitalizable Test & Simulation projects, partially offset by continued investment in new product development and the acquisition of Endevco. Excluding the impact of currency translation, research and development expense decreased 6.5% and 4.0%, respectively.
Income from Operations | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Income from operations | $ | 7,970 | $ | 24,174 | $ | (16,204 | ) | (67.0 | )% | $ | 23,128 | $ | 42,140 | $ | (19,012 | ) | (45.1 | )% | ||||||||||||
% of revenue | 3.8 | % | 10.4 | % | 5.5 | % | 9.7 | % | ||||||||||||||||||||||
Income from operations for the three and six months ended March 28, 2020 declined 67.0% and 45.1%, respectively, primarily due to lower gross profit, additional acquisition-related expenses in the current year and higher selling compensation expense in Sensors, partially offset by lower operating compensation expense in Test & Simulation. Excluding the impact of currency translation, the R&D acquisition, restructuring costs and the inventory acquisition adjustments and acquisition-related expenses in both fiscal years, income from operations decreased 38.3% and 25.2%, respectively.
38
Interest Expense, Net | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Interest expense, net | $ | 8,857 | $ | 7,368 | $ | 1,489 | 20.2 | % | $ | 17,129 | $ | 14,186 | $ | 2,943 | 20.7 | % | ||||||||||||||
Interest expense, net for the three and six months ended March 28, 2020 increased primarily due to higher interest expense on an increased debt position related to the issuance of the Notes in the fourth quarter of fiscal year 2019 and accretion on the contingent purchase price of R&D.
Other Income (Expense), Net | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Other income (expense), net | $ | (182 | ) | $ | 270 | $ | (452 | ) | (167.4 | )% | $ | (613 | ) | $ | 319 | $ | (932 | ) | (292.2 | )% | ||||||||||
The decrease in other income (expense), net for the three and six months ended March 28, 2020 was primarily driven by an increase in losses on foreign currency transactions.
Income Tax Provision | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Income tax provision | $ | 2 | $ | 2,916 | $ | (2,914 | ) | (99.9 | )% | $ | 1,151 | $ | 3,612 | $ | (2,461 | ) | (68.1 | )% | ||||||||||||
Effective tax rate | (0.2 | )% | 17.1 | % | 21.4 | % | 12.8 | % | ||||||||||||||||||||||
The effective tax rate for the three months ended March 28, 2020 decreased primarily due to a decrease in earnings.
The effective tax rate for the six months ended March 28, 2020 increased primarily due to certain discrete benefits of $1,293 in the prior year for the impacts of the Tax Act, as well as a discrete tax expense of $382 in the current year related to foreign dividend withholdings that are not creditable in the U.S. Excluding the impact of these discrete items, the effective tax rate for the six months ended March 28, 2020 and March 30, 2019 would have been 14.3% and 17.3%, respectively, and decreased primarily due to a decrease in earnings.
Net Income | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Net income | $ | (1,071 | ) | $ | 14,160 | $ | (15,231 | ) | (107.6 | )% | $ | 4,235 | $ | 24,661 | $ | (20,426 | ) | (82.8 | )% | |||||||||||
Diluted earnings per share | $ | (0.06 | ) | $ | 0.73 | $ | (0.79 | ) | (108.2 | )% | $ | 0.22 | $ | 1.27 | $ | (1.05 | ) | (82.7 | )% | |||||||||||
Net income and diluted earnings per share for the three and six months ended March 28, 2020 decreased primarily due to lower income from operations in both Test & Simulation and Sensors, partially offset by lower income tax expense from decreased earnings and increased interest expense.
39
Segment Results
Test & Simulation Segment
Results of Operations
The following tables compare results of operations for Test & Simulation, separately identifying the estimated impact of currency translation and the acquisition of R&D and restructuring costs incurred in the second quarter of fiscal year 2020. See Note 14 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information on our reportable segments.
Three Months Ended | ||||||||||||||||||||
Estimated | ||||||||||||||||||||
March 28, 2020 | Business Change | Acquisition / Restructuring1 | Currency Translation | March 30, 2019 | ||||||||||||||||
Revenue | $ | 125,497 | $ | (38,972 | ) | $ | 14,708 | $ | (1,271 | ) | $ | 151,032 | ||||||||
Cost of sales | 92,388 | (24,474 | ) | 14,318 | (1,198 | ) | 103,742 | |||||||||||||
Gross profit | 33,109 | (14,498 | ) | 390 | (73 | ) | 47,290 | |||||||||||||
Gross margin | 26.4 | % | 31.3 | % | ||||||||||||||||
Operating expenses | ||||||||||||||||||||
Selling and marketing | 15,765 | (2,991 | ) | 429 | (188 | ) | 18,515 | |||||||||||||
General and administrative | 15,752 | (2,797 | ) | 5,820 | (87 | ) | 12,816 | |||||||||||||
Research and development | 2,397 | (868 | ) | — | (10 | ) | 3,275 | |||||||||||||
Total operating expenses | 33,914 | (6,656 | ) | 6,249 | (285 | ) | 34,606 | |||||||||||||
Income from operations | $ | (805 | ) | $ | (7,842 | ) | $ | (5,859 | ) | $ | 212 | $ | 12,684 | |||||||
Six Months Ended | ||||||||||||||||||||
Estimated | ||||||||||||||||||||
March 28, 2020 | Business Change | Acquisition / Restructuring1 | Currency Translation | March 30, 2019 | ||||||||||||||||
Revenue | $ | 246,227 | $ | (42,854 | ) | $ | 14,708 | $ | (2,219 | ) | $ | 276,592 | ||||||||
Cost of sales | 176,148 | (26,007 | ) | 14,318 | (1,920 | ) | 189,757 | |||||||||||||
Gross profit | 70,079 | (16,847 | ) | 390 | (299 | ) | 86,835 | |||||||||||||
Gross margin | 28.5 | % | 31.4 | % | ||||||||||||||||
Operating expenses | ||||||||||||||||||||
Selling and marketing | 32,644 | (3,365 | ) | 429 | (283 | ) | 35,863 | |||||||||||||
General and administrative | 26,757 | (4,632 | ) | 6,687 | (185 | ) | 24,887 | |||||||||||||
Research and development | 4,487 | (1,561 | ) | — | (22 | ) | 6,070 | |||||||||||||
Total operating expenses | 63,888 | (9,558 | ) | 7,116 | (490 | ) | 66,820 | |||||||||||||
Income from operations | $ | 6,191 | $ | (7,289 | ) | $ | (6,726 | ) | $ | 191 | $ | 20,015 | ||||||||
1 | The Acquisition / Restructuring column includes operating results, costs incurred as part of the acquisition of R&D and $6,138 of restructuring costs. See Note 15 and Note 16 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information on restructuring and related costs and the R&D acquisition, respectively. |
40
Revenue | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Revenue | $ | 125,497 | $ | 151,032 | $ | (25,535 | ) | (16.9 | )% | $ | 246,227 | $ | 276,592 | $ | (30,365 | ) | (11.0 | )% | ||||||||||||
Revenue for the three and six months ended March 28, 2020 decreased 16.9% and 11.0%, respectively, primarily driven by lower volume from weakness in our ground vehicles and materials sectors and service, which were negatively impacted by COVID-19, specifically in Europe and Asia, and the unfavorable impact of currency translation. This decline was partially offset by contributions from the acquisition of R&D of $14,708 and volume growth in our structures sector. Excluding the impact of currency translation and the R&D acquisition, revenue decreased 25.8% and 15.5%, respectively.
Gross Profit | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Gross profit | $ | 33,109 | $ | 47,290 | $ | (14,181 | ) | (30.0 | )% | $ | 70,079 | $ | 86,835 | $ | (16,756 | ) | (19.3 | )% | ||||||||||||
Gross margin | 26.4 | % | 31.3 | % | (4.9 | ) | ppts | 28.5 | % | 31.4 | % | (2.9 | ) | ppts | ||||||||||||||||
Gross profit for the three and six months ended March 28, 2020 declined 30.0% and 19.3%, respectively, primarily due to lower revenue volume and restructuring costs of $3,868, partially offset by the gross profit contribution from the R&D acquisition and lower compensation expense. Gross margin declined 4.9 and 2.9 percentage points, respectively, primarily driven by restructuring costs and lower gross margin contribution from product mix, partially offset by lower compensation expense and the E2M inventory acquisition adjustment of $539 and $984, respectively, in the prior year. Excluding the impact of currency translation, R&D expenses, restructuring costs and the inventory acquisition adjustment in the prior year, gross profit declined 31.4% and 20.3%, respectively, and gross margin declined 2.4 and 1.9 percentage points, respectively.
Selling and Marketing Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Selling and marketing | $ | 15,765 | $ | 18,515 | $ | (2,750 | ) | (14.9 | )% | $ | 32,644 | $ | 35,863 | $ | (3,219 | ) | (9.0 | )% | ||||||||||||
% of revenue | 12.6 | % | 12.3 | % | 13.3 | % | 13.0 | % | ||||||||||||||||||||||
Selling and marketing expense for the three and six months ended March 28, 2020 declined 14.9% and 9.0%, respectively, primarily due to lower compensation and commission expense from fewer orders, partially offset by the addition of R&D expenses. Excluding the impact of currency translation, R&D expenses and acquisition-related expenses in the current fiscal year, selling and marketing expense decreased 16.2% and 9.4%, respectively.
General and Administrative Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
General and administrative | $ | 15,752 | $ | 12,816 | $ | 2,936 | 22.9 | % | $ | 26,757 | $ | 24,887 | $ | 1,870 | 7.5 | % | ||||||||||||||
% of revenue | 12.6 | % | 8.5 | % | 10.9 | % | 9.0 | % | ||||||||||||||||||||||
General and administrative expense for the three and six months ended March 28, 2020 increased 22.9% and 7.5%, respectively, primarily driven by the addition of R&D expenses, restructuring costs of $2,270 and R&D acquisition-related expenses of $464 and $1,331, respectively, partially offset by lower compensation expense due to headcount reductions, lower commission expense and E2M acquisition-related expenses incurred in the prior year of $186 and $947, respectively. Excluding the impact of currency translation, R&D expenses, restructuring costs and acquisition-related expenses incurred in both fiscal years, general and administrative expense decreased 20.7% and 15.4%, respectively.
41
Research and Development Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Research and development | $ | 2,397 | $ | 3,275 | $ | (878 | ) | (26.8 | )% | $ | 4,487 | $ | 6,070 | $ | (1,583 | ) | (26.1 | )% | ||||||||||||
% of revenue | 1.9 | % | 2.2 | % | 1.8 | % | 2.2 | % | ||||||||||||||||||||||
Research and development expense for the three and six months ended March 28, 2020 declined 26.8% and 26.1%, respectively, primarily due to the shift of internal resources to larger, capitalizable Test & Simulation projects, partially offset by continued investment in new product development. Excluding the impact of currency translation, research and development expense decreased 26.5% and 25.7%, respectively.
Income from Operations | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Income from operations | $ | (805 | ) | $ | 12,684 | $ | (13,489 | ) | (106.3 | )% | $ | 6,191 | $ | 20,015 | $ | (13,824 | ) | (69.1 | )% | |||||||||||
% of revenue | (0.6 | )% | 8.4 | % | 2.5 | % | 7.2 | % | ||||||||||||||||||||||
Income from operations for the three and six months ended March 28, 2020 declined 106.3% and 69.1%, respectively, primarily due to decreased gross profit on lower revenue volume, restructuring costs of $6,138 and R&D acquisition-related expenses of $473 and $1,340, respectively, partially offset by lower operating compensation expense, the contributions from the R&D acquisition and the E2M inventory acquisition adjustment in the prior year. Excluding the impact of currency translation, the R&D acquisition, restructuring costs, the inventory acquisition adjustment in the prior year and acquisition-related expenses in both fiscal years, income from operations decreased 63.9% and 42.0%, respectively.
42
Sensors Segment
Results of Operations
The following tables compare results of operations for Sensors, separately identifying the estimated impact of currency translation and the Endevco acquisition-related expenses incurred in fiscal year 2020. See Note 14 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information on our reportable segments.
Three Months Ended | ||||||||||||||||||||
Estimated | ||||||||||||||||||||
March 28, 2020 | Business Change | Acquisition1 | Currency Translation | March 30, 2019 | ||||||||||||||||
Revenue | $ | 86,198 | $ | 4,785 | $ | — | $ | (962 | ) | $ | 82,375 | |||||||||
Cost of sales | 48,062 | 5,717 | 600 | (556 | ) | 42,301 | ||||||||||||||
Gross profit | 38,136 | (932 | ) | (600 | ) | (406 | ) | 40,074 | ||||||||||||
Gross margin | 44.2 | % | 48.6 | % | ||||||||||||||||
Operating expenses | ||||||||||||||||||||
Selling and marketing | 14,366 | (348 | ) | — | (166 | ) | 14,880 | |||||||||||||
General and administrative | 10,245 | 33 | 950 | (27 | ) | 9,289 | ||||||||||||||
Research and development | 4,746 | 372 | — | (27 | ) | 4,401 | ||||||||||||||
Total operating expenses | 29,357 | 57 | 950 | (220 | ) | 28,570 | ||||||||||||||
Income (loss) from operations | $ | 8,779 | $ | (989 | ) | $ | (1,550 | ) | $ | (186 | ) | $ | 11,504 | |||||||
Six Months Ended | ||||||||||||||||||||
Estimated | ||||||||||||||||||||
March 28, 2020 | Business Change | Acquisition1 | Currency Translation | March 30, 2019 | ||||||||||||||||
Revenue | $ | 171,733 | $ | 13,192 | $ | — | $ | (1,784 | ) | $ | 160,325 | |||||||||
Cost of sales | 93,961 | 12,359 | 1,140 | (1,030 | ) | 81,492 | ||||||||||||||
Gross profit | 77,772 | 833 | (1,140 | ) | (754 | ) | 78,833 | |||||||||||||
Gross margin | 45.3 | % | 49.2 | % | ||||||||||||||||
Operating expenses | ||||||||||||||||||||
Selling and marketing | 30,206 | 910 | — | (325 | ) | 29,621 | ||||||||||||||
General and administrative | 20,933 | 869 | 1,829 | (61 | ) | 18,296 | ||||||||||||||
Research and development | 9,695 | 967 | — | (50 | ) | 8,778 | ||||||||||||||
Total operating expenses | 60,834 | 2,746 | 1,829 | (436 | ) | 56,695 | ||||||||||||||
Income (loss) from operations | $ | 16,938 | $ | (1,913 | ) | $ | (2,969 | ) | $ | (318 | ) | $ | 22,138 | |||||||
1 | The Acquisition column includes costs incurred as part of the acquisition of Endevco. The Endevco operating results are not separately identifiable as Endevco has been integrated into the existing Sensors business. See Note 16 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information on the Endevco acquisition. |
43
Revenue | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased /(Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Revenue | $ | 86,198 | $ | 82,375 | $ | 3,823 | 4.6 | % | $ | 171,733 | $ | 160,325 | $ | 11,408 | 7.1 | % | ||||||||||||||
Revenue for the three and six months ended March 28, 2020 increased 4.6% and 7.1%, respectively, primarily driven by growth in the Sensors test sector from a multi-year contract with the U.S. Department of Defense and contributions from the Endevco acquisition, partially offset by weakness in the other three Sensors sectors, specifically in the European and Asia regions, driven largely by COVID-19 and the unfavorable impact of currency translation. Excluding the impact of currency translation, revenue increased 5.8% and 8.2%, respectively.
Gross Profit | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Gross profit | $ | 38,136 | $ | 40,074 | $ | (1,938 | ) | (4.8 | )% | $ | 77,772 | $ | 78,833 | $ | (1,061 | ) | (1.3 | )% | ||||||||||||
Gross margin | 44.2 | % | 48.6 | % | (4.4 | ) | ppts | 45.3 | % | 49.2 | % | (3.9 | ) | ppts | ||||||||||||||||
Gross profit for the three and six months ended March 28, 2020 declined 4.8% and 1.3%, respectively, primarily due to the Endevco inventory acquisition adjustment of $600 and $1,140, respectively, higher compensation expense, the unfavorable impact from Endevco integration efforts and the unfavorable impact of currency translation, partially offset by increased revenue volume. Gross margin declined 4.4 and 3.9 percentage points, respectively, primarily driven by the unfavorable impact from Endevco integration efforts, lower gross margin contribution from product mix, the Endevco inventory acquisition adjustment and higher compensation expense during the ramp-up of manufacturing capacity to support new products and growth in order volume in a tight labor market. Excluding the impact of currency translation and the Endevco inventory acquisition adjustment, gross profit declined 2.3% and increased 1.1%, respectively, and gross margin declined 3.7 and 3.3 percentage points, respectively.
Selling and Marketing Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Selling and marketing | $ | 14,366 | $ | 14,880 | $ | (514 | ) | (3.5 | )% | $ | 30,206 | $ | 29,621 | $ | 585 | 2.0 | % | |||||||||||||
% of revenue | 16.7 | % | 18.1 | % | 17.6 | % | 18.5 | % | ||||||||||||||||||||||
Selling and marketing expense for the three months ended March 28, 2020 decreased 3.5% primarily driven by lower commission expense and the favorable impact of currency translation. Excluding the impact of currency translation, selling and marketing expense decreased 2.3%.
Selling and marketing expense for the six months ended March 28, 2020 increased 2.0% primarily driven by higher compensation from headcount additions to support sales growth, partially offset by lower commission expense and the favorable impact of currency translation. Excluding the impact of currency translation, selling and marketing expense increased 3.1%.
General and Administrative Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
General and administrative | $ | 10,245 | $ | 9,289 | $ | 956 | 10.3 | % | $ | 20,933 | $ | 18,296 | $ | 2,637 | 14.4 | % | ||||||||||||||
% of revenue | 11.9 | % | 11.3 | % | 12.2 | % | 11.4 | % | ||||||||||||||||||||||
General and administrative expense for the three and six months ended March 28, 2020 increased 10.3% and 14.4% primarily driven by acquisition-related expenses of $950 and $1,829, respectively, higher professional fees and higher compensation
44
expense due to planned headcount additions. Excluding the impact of currency translation and acquisition-related expenses, general and administrative expense increased 0.4% and 4.7%, respectively.
Research and Development Expense | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Research and development | $ | 4,746 | $ | 4,401 | $ | 345 | 7.8 | % | $ | 9,695 | $ | 8,778 | $ | 917 | 10.4 | % | ||||||||||||||
% of revenue | 5.5 | % | 5.3 | % | 5.6 | % | 5.5 | % | ||||||||||||||||||||||
Research and development expense for the three and six months ended March 28, 2020 increased 7.8% and 10.4%, respectively, primarily driven by the acquisition of Endevco and continued investment in new product development. Excluding the impact of currency translation, research and development expense increased 8.5% and 11.0%, respectively.
Income from Operations | ||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
March 28, 2020 | March 30, 2019 | Increased / (Decreased) | March 28, 2020 | March 30, 2019 | Increased / (Decreased) | |||||||||||||||||||||||||
$ | % | $ | % | |||||||||||||||||||||||||||
Income from operations | $ | 8,779 | $ | 11,504 | $ | (2,725 | ) | (23.7 | )% | $ | 16,938 | $ | 22,138 | $ | (5,200 | ) | (23.5 | )% | ||||||||||||
% of revenue | 10.2 | % | 14.0 | % | 9.9 | % | 13.8 | % | ||||||||||||||||||||||
Income from operations for the three months ended March 28, 2020 declined 23.7% primarily due to additional expenses related to the Endevco acquisition, partially offset by lower compensation expense. Excluding the impact of currency translation, the Endevco inventory acquisition adjustment and acquisition-related expenses, income from operations decreased 8.6%.
Income from operations for the six months ended March 28, 2020 declined 23.5% primarily due to additional expenses related to the Endevco acquisition, higher compensation expense and higher professional fees. Excluding the impact of currency translation, the Endevco inventory acquisition adjustment and acquisition-related expenses, income from operations decreased 8.6%.
Cash Flow Comparison
The following table summarizes our cash flows from total operations:
Six Months Ended | ||||||||
March 28, 2020 | March 30, 2019 | |||||||
Total cash provided by (used in): | ||||||||
Operating activities | $ | (2,579 | ) | $ | 30,669 | |||
Investing activities | (64,385 | ) | (91,450 | ) | ||||
Financing activities | 75,631 | 63,187 | ||||||
Effect of exchange rate changes on cash and cash equivalents | (22 | ) | (88 | ) | ||||
Increase (decrease) in cash and cash equivalents during the period | 8,645 | 2,318 | ||||||
Cash and cash equivalents balance, beginning of period | 57,937 | 71,804 | ||||||
Cash and cash equivalents balance, end of period | $ | 66,582 | $ | 74,122 | ||||
Operating Activities
The increase in cash used by operating activities was primarily due to lower net income and higher cash used by other assets and liabilities related to accrued project costs. These increases were partially offset by a decrease in cash used by working capital associated with timing fluctuations from accounts receivable payments received and unbilled accounts receivable accruals, accounts payable payments, inventory purchases, and advanced payments received from customers.
45
Investing Activities
The decrease in cash used in investing activities was primarily due to the acquisition of E2M in the first quarter of fiscal year 2019, partially offset by the acquisition of R&D in the second quarter of fiscal year 2020 and an increase in cash used to purchase property and equipment for continued strategic investments in the business.
Financing Activities
The increase in cash provided by financing activities was primarily due to an increase in borrowings under the Revolving Credit Facility used to fund the acquisition of R&D in the second quarter of fiscal year 2020 and operations. These increases were partially offset by borrowings under the Revolving Credit Facility used to fund the acquisition of E2M in the first quarter of fiscal year 2019.
Liquidity and Capital Resources
We had cash and cash equivalents of $66,582 as of March 28, 2020. Of this amount, $3,195 was located in North America, $33,874 in Europe and $29,513 in Asia. Repatriation of certain foreign earnings is restricted by local law. The North American cash balance was primarily invested in bank deposits. The cash balances in Europe and Asia were primarily invested in money market funds and bank deposits. In accordance with our investment policy, we place cash equivalent investments with issuers who have high-quality investment credit ratings. In addition, we limit the amount of investment exposure we have with any particular issuer. Our investment objectives are to preserve principal, maintain liquidity and achieve the best available return consistent with our primary objectives of safety and liquidity. As of March 28, 2020, we held no short-term investments.
As a result of the transition tax related to the enactment of the Tax Act, we are able to repatriate cash held in our foreign subsidiaries without such funds being subject to additional federal income tax liability. We plan to continue to repatriate certain amounts of our existing offshore cash and future earnings back to the U.S.
As of March 28, 2020, our capital structure was comprised of $36,600 in short-term debt, $575,371 in long-term debt and $481,678 in shareholders' equity. The Consolidated Balance Sheets also included $11,379 of unamortized debt issuance costs as of March 28, 2020. Total interest-bearing debt as of March 28, 2020 was $611,971. As of March 28, 2020, we had approximately $95,744 of unused borrowing capacity on the Revolving Credit Facility.
We have a credit agreement with a consortium of financial institutions (the Credit Agreement) that provides for senior secured credit facilities consisting of a Revolving Credit Facility and a Term Facility. The maturity date of the Revolving Credit Facility and the loans under the Term Facility is July 5, 2023, unless a term loan lender agrees to extend the maturity date pursuant to a loan modification agreement made in accordance with the terms of the Credit Agreement. The Credit Agreement also requires mandatory prepayments on our Term Facility in certain circumstances, including the potential for an annual required prepayment of a certain percentage of our excess cash flow.
Under the Credit Agreement, we are subject to customary affirmative and negative covenants, including, among others, restrictions on our ability to incur debt, create liens, dispose of assets, make investments, loans, advances, guarantees and acquisitions, enter into transactions with affiliates and enter into any restrictive agreements and customary events of default (including payment defaults, covenant defaults, change of control defaults and bankruptcy defaults). The Credit Agreement also contains financial covenants, including the ratio of consolidated total indebtedness to adjusted consolidated earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA), as defined in the Credit Agreement, as well as the ratio of Adjusted EBITDA to consolidated interest expense. These covenants restrict our ability to pay dividends and purchase outstanding shares of common stock. As of March 28, 2020, we were in compliance with these financial covenants. Specifically, we ended the second quarter of fiscal year 2020 with a leverage ratio of 4.5x, which is below the current maximum leverage ratio of 5.0x under the Credit Agreement.
In fiscal year 2019, we issued $350,000 in aggregate principal amount of 5.750% senior unsecured notes due in 2027 (the Notes). The Notes were issued pursuant to an Indenture among us, the Guarantors (as defined therein) and Wells Fargo Bank, National Association, as trustee (the Indenture). The Notes will mature on August 15, 2027.
The Indenture governing the Notes contains covenants that limit, among other things, our ability and the ability of our restricted subsidiaries to incur additional indebtedness or issue certain preferred shares; create liens; pay dividends, redeem stock or make other distributions; make investments; for our restricted subsidiaries to pay dividends to us or make other intercompany transfers; transfer or sell assets; merge or consolidate; enter into certain transactions with our affiliates; and designate subsidiaries as unrestricted subsidiaries. As of March 28, 2020, we were in compliance with these financial covenants.
See Note 9 to the Consolidated Financial Statements included in Item I of Part I of this Quarterly Report on Form 10-Q for additional information on our financing arrangements.
46
Shareholders' equity decreased by $2,381 during the six months ended March 28, 2020 primarily due to $11,509 dividends declared. The decrease was partially offset by $5,387 stock-based compensation and $4,235 net income.
As discussed, we have implemented various cost reduction initiatives to manage and reduce operating costs and further enhance our financial flexibility, both due to the COVID-19 pandemic and as a part of our general global restructuring effort in Test & Simulation. We have also suspended our quarterly dividend. While we cannot predict the overall impact of COVID-19 on our liquidity position, as of March 28, 2020, we believe our current capital resources will be sufficient to fund working capital requirements, capital expenditures and operations for the foreseeable future, including at least the next twelve months.
Off-balance Sheet Arrangements
As of March 28, 2020, we did not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Critical Accounting Policies
The Consolidated Financial Statements have been prepared in accordance with GAAP, which requires us to make estimates and assumptions in certain circumstances that affect amounts reported, giving due consideration to materiality, that affect the reported amounts of assets and liabilities, revenues and expenses and related disclosures of any contingent assets and liabilities at the date of the financial statements. We regularly review our estimates and assumptions, which are based on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Business Acquisitions
We account for acquired businesses using the acquisition method of accounting which requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values. The judgments made in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income. Accordingly, for significant items, we typically engage a third-party valuation firm. There are several methods that can be used to determine the fair value of assets acquired and liabilities assumed in a business combination. For intangible assets, we historically have utilized the "income method." This method starts with a forecast of all of the expected future net cash flows attributable to the subject intangible asset. These cash flows are then adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Some of the more significant estimates and assumptions inherent in the income method (or other methods) include the projected future cash flows (including timing) and the discount rate reflecting the risks inherent in the future cash flows. Estimating the useful life of an intangible asset also requires judgment. For example, different types of intangible assets will have different useful lives, influenced by the nature of the asset, competitive environment and rate of change in the industry. All of these judgments and estimates can significantly impact the determination of the amortization period of the intangible asset, and thus net income. Contingent consideration liabilities are remeasured to fair value each reporting period using projected revenues, discount rates, probabilities of payment and projected payment dates. Increases or decreases in the fair value of the contingent consideration liability can result from changes in the timing and amount of revenue estimates or in the timing or likelihood of achieving value-enhancing milestones, and changes in discount periods and rates. Projected contingent payment amounts are discounted back to the current period using a discounted cash flow model.
For further information, see Note 1, Note 3, Note 7 and Note 16 to the Consolidated Financial Statements included in Item 8 of our Annual Report on Form 10-K for the fiscal year ended September 28, 2019. For a discussion of our critical accounting policies, see "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in Item 7 of Part II of our Annual Report on Form 10-K for the fiscal year ended September 28, 2019.
Recently Issued Accounting Pronouncements
Information regarding new accounting pronouncements is included in Note 2 and Note 5 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q.
47
Other Matters
Dividends
Our dividend policy is to maintain a payout ratio that allows dividends to increase in conjunction with the long-term growth of earnings per share, while sustaining dividends through economic cycles. Our dividend practice is to target, over time, a payout ratio of approximately 25% of net earnings per share. We have historically paid dividends to holders of our common stock on a quarterly basis. The declaration and payment of future dividends will depend on many factors, including, but not limited to, our earnings, financial condition, debt repayment obligations, business development needs and regulatory considerations and are at the discretion of our Board of Directors. The quarterly dividend has been suspended as of the third quarter of fiscal year 2020. The reinstatement of the dividend will be considered in future periods at the discretion of the Board of Directors.
Forward-looking Statements
Statements contained in this Quarterly Report on Form 10-Q including, but not limited to, the discussion under Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, that are not statements of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the Act). In addition, certain statements in our future filings with the SEC, in press releases and in oral and written statements made by us or with our approval that are not statements of historical fact also constitute forward-looking statements. Examples of forward-looking statements include, but are not limited to: (i) projections of revenue, ROIC, Adjusted EBITDA, net income or loss, earnings or loss per share, the payment or nonpayment of dividends, our capital structure, the adequacy of our liquidity and reserves, the anticipated level of expenditures required and other statements concerning future financial performance; (ii) statements of our plans and objectives by our management or Board of Directors, including those relating to products or services, our restructuring initiatives, merger or acquisition activity and the potential impact of newly acquired businesses; (iii) statements of assumptions underlying such statements; (iv) statements regarding business relationships with vendors, customers or collaborators or statements relating to our order cancellation history, our ability to convert our backlog of undelivered orders into revenue, the timing of purchases, competitive advantages and growth in end markets; (v) statements regarding our products and their characteristics, fluctuations in the costs of raw materials for products, our geographic footprint, performance, sales potential or effect in the hands of customers; and (vi) statements about the impact of COVID-19 and related economic uncertainty. Words such as "believes," "anticipates," "expects," "intends," "targeted," "should," "potential," "goals," "strategy" and similar expressions are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements.
Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those in such statements. Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to, the currently-unknown impact of COVID-19 and related economic uncertainty and those described in Item 1A of Part I of our Annual Report on Form 10-K for the fiscal year ended September 28, 2019 and in Item 1A of Part II of this Quarterly Report on Form 10-Q. The performance of our business and our securities may be adversely affected by these factors and by other factors common to other businesses and investments, or to the general economy. Forward-looking statements are qualified by some or all of these risk factors. Therefore, you should consider these forward-looking statements with caution and form your own critical and independent conclusions about the likely effect of these risk factors on our future performance. Forward-looking statements speak only as of the date on which such statements are made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made to reflect the occurrence of unanticipated events or circumstances. You should carefully review the disclosures and the risk factors described in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019 and in other documents we file from time to time with the SEC, including our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
48
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Foreign Currency Exchange Risk
Over the past 15 years, approximately 70% of our revenue has been derived from customers outside of the U.S. Our international subsidiaries have functional currencies other than our U.S. dollar reporting currency and, occasionally, transact business in currencies other than their functional currencies. These non-functional currency transactions expose us to market risk on assets, liabilities and cash flows recognized on these transactions.
The strengthening of the U.S. dollar relative to foreign currencies decreases the value of foreign currency-denominated revenue and earnings when translated into U.S. dollars resulting in an unfavorable currency translation impact on revenue and earnings. Conversely, a weakening of the U.S. dollar increases the value of foreign currency-denominated revenue and earnings resulting in a favorable currency translation impact on revenue and earnings.
A hypothetical 10% appreciation or depreciation in foreign currencies against the U.S. dollar, assuming all other variables are held constant, would result in an increase or decrease in revenue of approximately $16,121 for the six months ended March 28, 2020.
We have operational procedures to mitigate these non-functional currency exposures. We also utilize foreign currency exchange contracts to exchange currencies at set exchange rates on future dates to offset expected gains or losses on specifically identified exposures.
Mark-to-market gains and losses on derivatives designated as cash flow hedges in our currency hedging program are recorded within accumulated other comprehensive income (loss) (AOCI) in the Consolidated Balance Sheets. Mark-to-market gains and losses are reclassified from AOCI to earnings in the same line item in the Consolidated Statements of Income and in the same period as the recognition of the underlying hedged transaction. Net gains and losses on foreign currency transactions included in the accompanying Consolidated Statements of Income were net losses of $1,138 and $309 during the six months ended March 28, 2020 and March 30, 2019, respectively. See Note 8 to the Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information on our cash flow hedge currency exchange contracts.
Interest Rates
We are directly exposed to changes in market interest rates on cash, cash equivalents, short-term investments and long-term debt, and are indirectly exposed to the impact of market interest rates on overall business activity.
On floating-rate investments, increases and decreases in market interest rates will increase or decrease future interest income, respectively. On floating-rate debt, increases or decreases in market interest rates will increase or decrease future interest expense, respectively. On fixed-rate investments, increases or decreases in market interest rates do not impact future interest income but may decrease or increase the fair market value of the investments, respectively. On fixed-rate debt, increases or decreases in market interest rates do not impact future interest expense but may decrease or increase the fair market value of the debt, respectively.
As of March 28, 2020, we had cash and cash equivalents of $66,582, some of which was invested in interest-bearing bank deposits or money market funds. The interest-bearing bank deposits and money market funds have interest rates that reset every 1 to 89 days and generate interest income that will vary based on changes in short-term interest rates. A hypothetical decrease of 100 basis points in market interest rates, assuming all other variables were held constant, would decrease interest income by approximately $36 for the six months ended March 28, 2020.
As of March 28, 2020, we had floating interest rate debt of $261,971. Secured floating rate credit facilities require interest payments to be calculated at a floating rate tied in part to LIBOR or, if LIBOR is no longer available, at a replacement rate to be determined by the administrative agent for the Credit Facility and consented to by us. As a result, changes in floating rate can affect our operating results and liquidity to the extent we do not have effective interest rate swap arrangements in place. A hypothetical increase of 100 basis points in floating interest rates, assuming all other variables were held constant, would result in an approximately $2,404 increase in future annual interest expense.
49
Item 4. Controls and Procedures
Our management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)), as of March 28, 2020. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 28, 2020, our disclosure controls and procedures were effective.
There were no changes in our internal control over financial reporting during the second quarter of fiscal year 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
We are subject to various claims, legal actions and complaints arising in the ordinary course of business. We are not presently a party to any litigation the outcome of which we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows or financial condition.
Item 1A. Risk Factors
A discussion of our risk factors can be found in Item 1A of Part I of our Annual Report on Form 10-K for the fiscal year ended September 28, 2019. The information below includes an additional risk relating to COVID-19. The risks described below and in our Annual Report on Form 10-K are not the only risks we face. Additional risks not currently known to us, or that we currently deem to be immaterial, may also adversely affect our business, financial condition or results of operations in future periods.
The extent to which the outbreak of COVID-19 and measures taken to contain the outbreak will negatively affect our financial condition and results of operations is highly uncertain and cannot be predicted.
Our global operations expose us to risks associated with public health crises and pandemics, such as the outbreak of COVID-19. Attempts to slow the spread of COVID-19 implemented by governments across the globe, including travel bans, restrictions on gatherings, shutdowns of business and government facilities, shelter in place orders, and quarantines, have impacted and will continue to impact our workforce and operations, the operations of our customers, and the operations of our vendors and suppliers.
We have significant manufacturing operations in North America, Europe and Asia, and each of the countries in which we operate has been affected by the outbreak and taken measures in an attempt to contain it. There is considerable uncertainty about the magnitude and duration of the effect that containment measures will have on our operations and the operations of our suppliers and customers. The number of jurisdictions in which we operate will add complexity to our efforts to operate under these restrictions. We also operate with a global supply chain, and both restrictions on the operations of our suppliers and regulation of the international movement of goods may prevent us from timely completing customer orders.
If the COVID-19 outbreak continues and conditions worsen, we may continue to experience a decline in sales activities and delays in customer orders, and it remains uncertain what impact these declines will have on future sales and customer orders once conditions begin to improve. Many of our customer orders are part of large capital expenditures and the financial uncertainty resulting from COVID-19 and its market impacts may cause customers to delay planned capital expenditures.
The extent to which the COVID-19 outbreak impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak, the severity of the outbreak, the actions of governments and private actors to slow the spread of the outbreak, the effect of fiscal stimulus measures, and how quickly and to what extent normal economic and operating conditions can resume. We do not yet know the full extent of the impact on our business, our operations or the global economy as a whole. However, the effects could have a material impact on our results of operations, and we will continue to monitor the COVID-19 situation closely.
50
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents repurchases of our equity securities we made during the fiscal quarter ended March 28, 2020:
Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs | Maximum Number of Shares that May Yet be Purchased As Part of Publicly Announced Plans or Programs | ||||||||||
December 29, 2019 – February 1, 2020 | — | $ | — | — | 438 | ||||||||
February 2, 2020 – February 29, 2020 | — | $ | — | — | 438 | ||||||||
March 1, 2020 – March 28, 2020 | — | $ | — | — | 438 | ||||||||
We purchase common stock from time to time to mitigate dilution related to new shares issued for employee compensation such as stock options, restricted stock units, performance restricted stock units and for employee stock purchase plan activity, as well as to return to shareholders capital not immediately required to fund ongoing operations.
Share Purchase Plan
Our Board of Directors approved, and on February 11, 2011 announced, a purchase authorization of 2,000 shares. Authority over pricing and timing under the authorization has been delegated to management. The share purchase authorization has no expiration date. We made no share purchases during the second quarter of fiscal year 2020. As of March 28, 2020, there were 438 shares available for purchase under the existing authorization.
Item 6. Exhibits
Exhibit Number | Description | |||
10.1 | ||||
31.1 | ||||
31.2 | ||||
32.1 | ||||
32.2 | ||||
101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document (filed herewith). | |||
101.SCH | XBRL Taxonomy Extension Schema Document (filed herewith). | |||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith). | |||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document (filed herewith). | |||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document (filed herewith). | |||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith). | |||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) (filed herewith). | |||
51
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MTS SYSTEMS CORPORATION | |||
Date: | May 4, 2020 | /s/ JEFFREY A. GRAVES | |
Jeffrey A. Graves | |||
President and Chief Executive Officer | |||
(Principal Executive Officer) | |||
Date: | May 4, 2020 | /s/ BRIAN T. ROSS | |
Brian T. Ross | |||
Executive Vice President and Chief Financial Officer | |||
(Principal Financial Officer and Principal Accounting Officer) | |||
52